Podcasts about Stryker

Medaya Ocher and Eric Newman speak with Susan Stryker about her new book Changing Gender. Part cultural history, part grammar lesson, and part memoir, Changing Gender confronts not only the long historical slipperiness of gender and identity in U.S. culture, but also the ways in which the very language we use to describe and understand gender becomes a cultural battleground for meaning and identity. Stryker discusses the relatively recent origins of our thinking about "gender," the ways that thinking has been misunderstood and misappropriated for political skirmishes, and the difficulty of pinning down exactly what we're talking about when we talk about gender.

Twenty years of war left many veterans with a range of reactions, including frustration, uncertainty, and unresolved questions. Retired Army officer Paul Darling offers his perspective based on a 27-year career, a 2009 deployment to Afghanistan, work at the Pentagon, and his book Taliban Safari. He discusses how decisions are made about equipment, how budgets are managed, and why accountability at senior levels is often debated. The conversation covers topics such as the Stryker, F-35, A-10, and close air support, as well as Pakistan's role in Afghanistan, the collapse of Afghan forces, and the broader impact on those who served. Paul also talks about his involvement with War 102, the Tennessee State Guard, and Real Plastic Heroes as ways to stay engaged after retirement. Listeners will hear one perspective on how institutional incentives may influence outcomes, why reflection after conflict can be complex, and how veterans can explore different paths through service, education, and community. Timestamps: 00:05:02 - Reflections on Afghanistan's outcome 00:07:54 - Adjusting after combat experience 00:25:15 - Debates around senior-level accountability 00:38:14 - The final withdrawal and leadership decisions 00:45:47 - State guard involvement after service Links & Resources Veteran Suicide & Crisis Line: Dial 988, then press 1 Website: https://war102.buzzsprout.com Follow Paul Darling on LinkedIn: https://www.linkedin.com/in/paul-darling-aa06231bb/

Market Mondays is back with a breakdown of the biggest stories moving markets. We cover the bond market, what history says about stocks around midterm elections, warning signs from the VIX, and the biggest investing mistakes people are making right now.We dive into NVIDIA ahead of earnings, Jensen Huang's AI strategy, changing valuations, memory pricing, Micron, CrowdStrike, and the future of the AI trade. We also look at McDonald's as an economic signal, CAVA vs. Chipotle, and why time in the market can beat constantly trading.Plus, we close with audience questions and a rapid-fire This or That featuring Costco vs. McDonald's, Tesla vs. BYD, Robinhood vs. Meta, Bloom Energy vs. JPMorgan, Google vs. Stryker, and more. #MarketMondays #Investing #StockMarket #NVIDIA #NVDA #AI #Bitcoin #Trading #Finance #Wealth #EarnYourLeisureAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Saul Marquez is a prominent figure in healthcare digital marketing, serving as the founder and CEO of Outcomes Rocket, a global digital marketing agency serving healthcare clients exclusively. With over twenty years of experience in sales and marketing within the healthcare sector, Saul's journey began in sales and leadership roles at major players like Stryker, NuVasive, and Medtronic. Recognizing significant gaps that companies were faced with in strategy, digital marketing, and commercialization during his career, Saul established Outcomes Rocket to address these challenges head-on. The consultancy focuses on helping healthcare brands and businesses scale and thrive in the digital age.

A practicing pathologist explains why DaVita, UnitedHealth, and Natera are playing fundamentally different games — and why one of them could break first.Investing in healthcare stocks requires a different framework than semiconductor investing. In this excerpt from a CSI live Q&A, we sit down with Dr. Brad Gibson — a practicing pathologist and private-practice partner — to break down how the US healthcare system actually gets paid, and what that means for stock picking.Brad walks through four investable buckets: medical service providers (DaVita, Natera, TransMedics), health insurers (UnitedHealth, CVS, Cigna, Elevance), pharmaceutical companies (Eli Lilly, Vertex), and healthcare hardware/software providers (Stryker, Veeva, Intuitive Surgical).The conversation covers Medicaid and Medicare reimbursement mechanics, CPT codes and RVU conversion factors, why private practices are being pushed into hospital consolidation, how pharmacy benefit managers generate profit through rebates, and why UnitedHealthcare's vertical integration has drawn regulatory scrutiny. Brad also gives his take on AI in pathology and drug discovery, and explains why he's more concerned about a healthcare cost bubble than an AI bubble.If you're building a healthcare investing thesis for 2026, this is where to start.If you want the reasoning behind more names like this one, Semiconductor Insider covers the process in more depth: https://www.chipstockinvestor.comAll our socials: https://linktr.ee/chipstockinvestorContent in this episode is for general information or entertainment only and is not specific or individual investment advice. Forecasts and information presented may not develop as predicted, and there is no guarantee any strategies presented will be successful. All investing involves risk, and you could lose some or all of your principal.

Stop the presses—one of the great mysteries of Marx Brothers fandom has finally been solved! After decades of anonymity, the manicurist from A Night at the Opera has a name. Bob Stryker joins us to explain how he stumbled onto the elusive answer, and we follow the story from a brief onscreen appearance to her surprising later career working behind the scenes in Hollywood.

At some point in their training or careers, most clinicians will experience intense stress, suffering, loss and critical incidents that can have lasting impacts on their psychological and emotional safety. Despite the prevalence of traumatic stress in healthcare settings, most care team members are not taught about the effects it can have on their mind and bodies. As a result, they normalize traumatic stress symptoms such as exhaustion, difficulty concentrating, emotional disconnection, or the inability to be fully present. In this episode of Caring Greatly, Marie Nutter, BSN, RN, CNOR, a practicing perioperative nurse and trauma-sensitive yoga educator, explores how traumatic stress shows up in the lives and bodies of healthcare workers. Marie describes how traumatic stress gets internalized when stress, grief and loss go unprocessed over time. Drawing from both her professional experience as a nurse and her own journey through personal loss, Marie shares how care team members often learn to push through adversity, only to discover that unresolved stress eventually returns through exhaustion, disconnection and difficulty of concentrating or being fully present.The conversation delves into the power of trauma-informed approaches to healing, including the role of body awareness, grounding practices and trauma-sensitive yoga. Marie explains how small, intentional moments of reconnecting with the body can help restore a sense of choice, presence and control. She also offers reflections on what healthcare organizations and leaders can do to better support their teams, emphasizing that trauma recovery is a shared responsibility that begins with recognizing that trauma is a natural adaptive response. Additionally, leaders can offer compassionate support and provide access to trauma-informed resources. As a seasoned nurse at M Health Fairview Masonic Children's Hospital in Minneapolis, a trauma-sensitive yoga facilitator, and founder of Mayday Yoga, LLC, Marie educates people about the effects of traumatic stress and loss and how they might mitigate day-to-day exposure in real-time. Through 15 years of navigating high demands of perioperative nursing, 10 years of personal yoga practice, and seven years of offering trauma-informed wellness services to the healthcare community, Marie has learned that people's professional and human credibility are not defined by their ability to withstand difficult work-life events. In 2020, Marie was named an example of resiliency by Psychology Today Magazine, and she continues to offer individuals and work teams an opportunity to tap into their own inner wellness.Marie Nutter is a leader who cares greatly.Related links:Website: Mayday YogaArticle: 5 Mind-Body Exercises to Help Reduce Traumatic Stress Book: Trauma Stewardship: An Everyday Guide to Caring for Self While Caring for OthersThe views and opinions expressed in this podcast are those of the speakers and do not necessarily reflect the views or positions of Stryker. The provided resources may contain links to external websites or third-party content. We do not endorse, control or assume any responsibility for the accuracy, relevance, legality or quality of the information found on these external sites. Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Code Lavender, Caring Greatly, Stryker. All other trademarks are trademarks of their respective owners or holders.

Dave Rosa shares how a lifelong drive to help others and his own health challenges led him into 32 years across orthopedics, cardiovascular, and neuro. Dave walks through his path from early marketing roles to becoming a CEO, and explains the innovation behind NeuroOne's electrode platform designed to combine diagnosis and treatment in a single procedure—starting with epilepsy, expanding to trigeminal neuralgia, and now targeting lower back pain. He also discusses early work using the same technology for precise drug delivery to the brain, including a program focused on glioblastoma. Dave closes with leadership lessons on vision, culture, learning from mistakes, and giving back.    Guest links: https://nmtc1.com/ | https://www.linkedin.com/company/n1mtc/ Charity supported: Opportunity International Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 086 - Dave Rosa [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm delighted to welcome as my guest, Dave Rosa. Dave is an entrepreneur with three decades of experience in the medical device industry, spanning a variety of technologies and products. In addition to CEO roles with early-stage medical device companies, Mr. Rosa's background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development, and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised 200 million in the capital markets. Well, Dave, thank you so much for being here today. I am absolutely delighted to have you on the show. [00:01:33] Dave Rosa: Well, thanks for having me. [00:01:34] Lindsey Dinneen: Yeah, of course. I would love, if you wouldn't mind, by starting out and just telling us a little bit about yourself, your background, and what led you to medtech? [00:01:45] Dave Rosa: Yeah. So, born and raised in a small town called Richport, Pennsylvania, outside of Philadelphia. And really was in love with the medtech industry from the time I was much younger. So I, I have been in medtech now, it's going on 32 years and that's everything from large medical device companies to, to startup companies. I've been in so many different areas of medtech. I've been in orthopedics, cardiovascular, and I mean everything involving the heart, I've been in it in some way, shape, or form, a-a-as well as neuro, which is what I'm in now. And, and I think, you know, why did I get into medtech? I think this all goes back to when I was a little kid. You know, I, I was the little kid that was walking street people to my house and bringing them into my home for my mom to make a meal. I don't know that she always appreciated that me doing that, but, but there, there were more than enough times where she sat me down and I was maybe only four or five years old, and she's like, "Honey I, I, I know you wanna help people, but you can't bring everyone home." And I was like, "Oh, oh, you know, okay, Mom." Of course, until the next time. But, you know, I think it started at an early age and, and really has carried through you know, the rest of my career [00:03:07] Lindsey Dinneen: Yeah. Yeah, okay. So you've always been interested in helping people, and you've had a really nice variety of experiences within medtech. But tell us about your path from that early just interest and care in, in people and their wellbeing, to perhaps your educational journey and maybe, like, the first little bit of your career that led you to where you are now. [00:03:32] Dave Rosa: Yeah. So, in high school I was involved in sports and, and even prior to high school, and I had so many physical issues. So I had initially a shoulder problem that was I'll, I'll say pretty complicated, at least back in those times. And what I found is by the time I got to college, and, you know, I'm still trying to figure out what I wanna do with with my life and what career I wanna take. I, I was actually in chemical engineering, but came, came to the conclusion that I hated chemistry, which, which didn't help things out. And, and I really knew, you know, my, my passion was on the medical side, and a lot of it, you know, was driven because of my own issues, my own shoulder issues, because it really put a damper on, you know, any, any potential I had at especially playing baseball. So, so, i- in college, I went to Drexel University, there really wasn't a course for biomedical, undergraduate biomedical engineering that was, like, a graduate program. And, you know, I, I decided that I would take courses in electrical engineering and a program called commerce and engineering, which kinda merges both the business and engineering side of the equation. So, I, I actually started out not in medical. I was in electrical engineering, and I was probably one of the worst electrical engineers working at Westinghouse at the time. And I remember one of the managers saying to me, he's like, "You know, all, all the other engineers and marketing people really like working with you. Why is that?" And I said, "I, I really don't know other than, you know, I've always been a passionate person about whatever I'm doing." So, you know, so at that point, I started thinking that engineering was not the path for me, that you know, that I was really more, much more passionate about medical because it was impacting my life with my shoulder. And then by that time, you know, my knees and everything else started to go as well. But I graduated with a degree in commerce and engineering, and then after working a few years in electrical engineering for Westinghouse Electric I just started knocking on doors because I, I really-- my passion was, you know, helping others, and I wanted to be involved in an area that might help me being orthopedics. So that, that's kinda how I got my first job, knocking on doors, and Stryker Instruments decided they would take a chance on me, and that, that was kind of the beginning. [00:06:12] Lindsey Dinneen: Very nice. And so when you found medical device, was it this really exciting moment of realizing that it could marry your interests in engineering and your desire to help people? Was that like just this cool moment of going, "Oh, wow, like I, I can do both"? [00:06:31] Dave Rosa: Yeah. I, I, you know, I remember actually praying about this, like, "What am I supposed to do?" Like, you know, and, and "How do I go about this?" And I don't know, you know, it, it, it brought back some memories you know, of when my father was you know, was at the end of his life, and he was this stern Italian man. Never, you know, never-- there, there was no discussion about feelings or anything like that. It was like, "You do what I tell you to do. You, you talk when I tell you to talk. Otherwise, you know, you say nothing." So my, my dad's literally on his deathbed, and he says to me, "You know, I, I really wanna thank you, son, for taking care of your mother and I all these years with, you know, medical decisions." And he said, "You know, you, you always were helping people from the time you were a little boy." And it actually stunned me that my dad, who never appeared to be paying attention to anything regarding me, was like, "Hey, you know, you, you know, you really cared about helping people, not just us, but, you know, this, this goes back to the beginning for you." So it, it was also more of a reinforcement of like, "Yeah, I've, I've really gotta be in medtech, and I'm gonna start with, you know, how I can help my own issues and/or, you know, family's members' issues that they may have." [00:07:52] Lindsey Dinneen: Mm-hmm. Yeah. Yeah. I think sometimes we don't realize the impact that we're making at the time and being able to just do what we feel is right and, and what we know helps others can actually make an impact, and then hopefully we get those opportunities like you got with, with your father to s- realize eventually, "Oh, okay, yeah, I, I am, I am on the right path doing, doing the right thing at this time." So yeah, it's great to have those moments of reinforcement, but. [00:08:26] Dave Rosa: And if you fast-forward, you know, to something again, just more reinforcement, although it's much later in my career and I've had other moments like this, but this was just last month. I was at, at a memorial service for one of the physicians that used our product to treat a, a young lady, she was 17 years old at the time for epilepsy. And so the doctor that performed a procedure on her had a tragic accident, passed away, and we were all at this memorial service for him. And the father along with the mother and, and this young lady who's now in college, they came up to me you know, we were, you know, just chatting about how unfortunate the situation is. And when I got ready to, you know, go back to the service he said to me "Sir, I, I just wanna thank you for giving my baby girl her life back." And I mean, those kinds of things, when, when people say those things to you, and like I said, it's happened more than once, and, and it's because of something, you know, that you've you know, committed the, the company to accomplishing, and then you see results like this, there's nothing more rewarding than that. [00:09:39] Lindsey Dinneen: Yeah, of course. Yeah. Thank you for sharing that. So, all right, so in fast-forwarding a little bit you, you started in medtech with Stryker, and then what gave you-- and, and there's probably maybe some things in between-- but what gave you the the idea for what you're doing now? And can you just take us along that journey from starting out in medical device to where you are now, including that just pathway to even, to even higher roles in leadership and that learning curve as well? [00:10:12] Dave Rosa: Yeah, that's-- boy, that's a long story when you've been in it for 30-some years. You know, I, I started out in marketing. I always liked the interaction between customers, meaning, you know, physicians, patients, when, you know, we had the opportunity to, you know, to speak to the patient. And then, you know, I, I I would like to think that maybe some of my decision-making and, and some of my ideas, you know, led to success in some of these companies. And you know, I think upper management you know, wa-was able to identify that I might have some of the, the qualities that they were looking for really in the next generation of leaders. And this goes back to you know, my, my first job in the cardiovascular industry. Gosh, this was in 1995, so, about 30 years ago with Boston Scientific. And I was able to go from a Product Manager to a Director of Marketing. And I was there for a total of about four years, and I, I really enjoyed the strategic part of the job, and I, I wanted to be more involved in that. And I got an opportunity to go to a startup to run sales and marketing also in the cardiovascular space. And that was a, a great experience because, you know, in smaller companies, and this, by the way, was my first opportunity in a smaller company, you know, you, you have to wear a lot of hats. And I liked, I always liked to be more hands-on and still am, to be honest, and, you know, th-this gave me an opportunity to really you know, get involved in more than just what the job detail or the job description called for. And, you know, the-these things all, sometimes, you know, require some luck but definitely, you know, the right timing. And an opportunity in the startup company that I left Boston Scientific for became available at the CEO level, and the the investors-- the company was funded by venture capitalists-- met with me and said, "You know, we, we think you can take the company to the next level." And I think that was back in 2003, and pretty much been a CEO ever since then. But I, you know, I think a lot of the success comes from and confidence from, you know, the, the hiring companies. I, I think what people notice about me is my passion, my, my commitment, and, and probably the fact that you know, I, I think one of the things I'm strong with is developing a, a, a vision. I mean, that's, that's something that I think is really critical with leaders is that you, you've gotta develop a vision for the company, a strategy for the company so that others can understand what the goals are. So that, that's kinda my path. It's, you know, it's, it's I would say every four to five years I've had an opportunity to either start a company or run a company. And then NeuroOne, which is, you know, my current company, I was actually retired when I was approached by a few individuals who had this idea. And what started out as me just, you know, helping them turned into "Gosh, we would love you to run the company." And I really thought there was an opportunity there, you know, to help people who suffered from these neurological disorders, primarily brain-related disorders. But, you know, that, that vision has kind of expanded beyond just the brain into other areas of the body. [00:13:56] Lindsey Dinneen: Wow. Yeah. Okay, yeah. I appreciate you sharing more about your journey. I love the fact that you're both an engineer and you have this creative side with marketing, and you're able to marry all that together. That's, that's really cool, and gives you such a unique perspective on, you know, I would say product development and then commercialization. But okay, so let's talk about your company now, and what are you excited about? What are some of the innovations coming out of it? You mentioned that it sort of s- it started in one place and one focus, and now we get to see it expanding. And so I'd just love to hear all about your company as well. [00:14:33] Dave Rosa: Sure. So, we started out with the intention to develop this electrode technology, and initially it was primarily to be used for brain-related procedures for patients, initially at least, that were suffering with epilepsy. And this, this technology, the, the idea was "Let's combine functions with this" in that it, it, it would have the ability to perform a diagnostic function. And for these patients, the diagnostic function was finding the area in the brain that was triggering these issues. And then once you were able to accomplish that, then using the same device, destroy that brain tissue that was causing the problem in an effort to eliminate the seizures that patients were having. So that, that's kind of where we started. We, we are selling that technology. We have a distribution partner, Zimmer Biomet, that is our exclusive distributor for that technology, and we've had great success in treating patients. You know, the story that I told about the father you know, who thanked me for getting his daughter's life back, that's what that technology is used for. And the-- really what patients had to face before this technology was available is they would have to have a very invasive surgery just for the diagnostic part of the procedure. So the part where you're just trying to identify the problem area, that was one surgery. And we're, we're talking about, you know, drills that are drilling holes, you know, through the skull with these devices being placed in the brain. And then once that part was done, the patients would go home, and they would be scheduled for a follow-up procedure where they would have to come back again, have an invasive procedure in-into the brain, and then that, that second procedure would be the one where they would eliminate or destroy the problematic brain tissue. So if you're a patient, two invasive surgeries, two hospitalizations, two separate devices, and we said, "Why can't you do it with one?" And, and that's, that's where we are. We then more or less leveraged that technology to treat a a condition called trigeminal neuralgia, which is this excruciating facial pain that patients will experience. And it, there-- it's very well known to carry a a high rate of suicide because of how painful this condition is. But we were able to leverage the same system and provide the neurosurgeon you know, with, with a very unique tool to treat that condition. We also-- what I'm also excited about is these-- the, the same platform we're using now to develop technology to treat lower back pain. There's different types of lower back pain. We, we happen to be focusing on two. One that involves issues with the basivertebral nerve, which is a l- a nerve in the lower spine. And then the more common back pain where you have pain that's traveling down the leg, that's sciatic nerve pain. So we've been able to use the same electrode to to develop technologies, unique technologies that would be able to treat that condition. And then finally, drug delivery. These electrodes have a hollow center and we've been able to demonstrate in animals so far that not only can you use it for diagnostics and stimulating through, but you can also deliver therapeutic agents directly into the brain, specifically where you would like to deliver them. And we, we've initiated a program to try to improve really the care for patients that suffer from glioblastomas, which are those brain tumors that carry high rates of mortality. [00:18:45] Lindsey Dinneen: Wow. Wow. Well, there is an incredible amount of innovation coming out of the company, and I'm so excited to follow along and just see all of the difference that you're gonna make in patients' lives. So gosh, first of all, thank you for what you're doing. I, I'm curious, you know, you, you've had such a great career and so many different opportunities to grow into more and more leadership roles. And I, I'm wondering, first of all, what your own leadership philosophy is, sort of as a whole, and then maybe some examples of both good and not as ideal leadership that helped to shape it. [00:19:28] Dave Rosa: Yeah. So, I mean, for me, you know, the, the people that I've always looked at that I think are great leaders are, are those people that can communicate a vision and, and really instill a passion to inspire others in the company to have the same sort of passion to achieve this, this overall vision or this overall strategy. And, you know, I, you know, I-- there, there have been clearly people that I've worked for in my life that I've said, "Gosh you know, they, they really were inspirational to me to be better," not just I would say as a leader, but just more effective overall. And, you know, I, I, you know, I, I-- when I look at my own areas that when I think about leadership and what I can do to, to be more effective, you know, I some of the areas that I've personally looked at i- are things that can make the company more efficient. And artificial intelligence is probably the one that gets, you know, the most attention today. And, and I'm looking to using it, and took a course in this actually to, to really become more efficient and help the company be more efficient in, in developing these technologies and getting them to market as, as quickly as possible. And, and I think, you know, for myself, I'm, I'm very fortunate to be surrounded by a board of directors that I look at that I think have excellent leadership qualities, and it's, it's really, you know, meeting with them on a... and, and just talking to them on a fairly regular basis, picking their mind to see how they would handle things because, you know, I'm, I'm really the, the product of stealing ideas from other people that, that I think you know, have worked well and led to the success of companies and people that they've led. So it's, it's not necessarily taking a course on leadership, but it's surrounding yourself with people that have been successful in leading groups and, you know, getting ideas from them on how to be more efficient, whether it's, you know, taking classes you know, in, in things like AI or, or just, you know, learning from their own success as to how to inspire people to, you know, to really finish the goal for whatever that goal is. [00:21:58] Lindsey Dinneen: Yeah. Yeah, and speaking of inspiring people, how do you as a leader intentionally help shape the company culture that you feel is best for, for people to thrive in? [00:22:13] Dave Rosa: Yeah. So I've, I've always been of the mindset that companies that perform the best utilize ideas that others on the team have. So there, there are, I, I'll give you a great example. I-I find that people that come from big companies have more of a mindset of execution, meaning, "So whatever the boss tells me to do, I do and I'm, I'm not gonna challenge them." So it's, it's one more of, "I, I find out what I need to do and, and and I execute that." You know, in, in our company, one of the things I try to foster is that it's okay to have a, a different opinion. We're all here, you know, trying to be successful, and none of us have all the answers. Now, there's gonna be times when we as a, a team just can't agree, and when those times occur, then, you know, the, the CEO is going to have to make the final decision because that's in my mind, that's, that's really one of the roles of the CEO. But I can tell you, in our company and in other companies I've been in, a lot of the, the great ideas on what to do, you know, have really come from others. They haven't, they haven't come from me. I'm-- I may be setting the overall vision, but sometimes, you know, you, you take a small detour because someone in the group who wasn't afraid to speak up, you know, has an idea or a thought that you know, makes the, the outcome more successful, whether it's shortening the time or coming up with a different idea, a different concept. I constantly try to hi- hire people that have skill sets that I don't have. So for example, I recently, within the last two months hired a guy that had great experience in the pharma space and really how to navigate that space and understands the, the therapies that are out there. And in a very short period of time you know, I realized, "Gosh, this guy, you know, knows so much more than I know and I'm gonna learn a lot from him." So I think it's, it's, it's really empowering the people that you hire, you know, to express what their thoughts and their ideas are because I don't care what CEO you're talking about, none of us, you know, have all the answers. [00:24:33] Lindsey Dinneen: Yes. And recognizing that is, is definitely, I think, key. I think a lot of the leaders that I've been talking to recently talk about exactly what you've mentioned. It's, it's recognizing that y- you know, you, you, you do have your blind spots or your just, your areas of weaknesses, and that's okay 'cause we all do, right? But as long as you're willing to say, you know, "Okay, this might not be my area, but I trust the person whose area I know it is," then, then that's just such a great way to, to handle that and empower the next generation of leaders. So yeah, I love that that's your approach. [00:25:10] Dave Rosa: I also, you know, I, one other area that I think is also critical, and it goes back to what I said about individuals that I've met in larger companies, and I experienced this when I was in a larger company as well. You know, the focus becomes not making a mistake. And and, and it's because you know, the, these employees don't wanna make a mistake that's going to cost them their career in that company. So the safest thing to do is to do what your supervisor tells you to do, as opposed to take a chance and, you know, offer a different idea or a different concept. It's seen as risky and it's because there's this fear of making a mistake. I think it's smaller companies, especially in companies that I've run, you know, my, my philosophy is it's okay to make a mistake, but let's not make the same mistake more than once. I mean, they're, they're there to learn from. So let, let's, let's be smarter the, the second time, you know, because of that experience. But if people are afraid to make mistakes, you'll, you know, you're, you're never gonna get different ideas or different concepts you know, out, out, out amongst the group because of the fear of making a mistake. [00:26:26] Lindsey Dinneen: Mm-hmm. Right. Yeah, absolutely. Providing that, that opportunity and I, I know it's a bit of a cliche, but the, the idea of a safe environment at least to present those ideas and potentially counter opinions, and that's where creativity thrives is when you can iterate and bounce ideas off each other and, and come up with something that's, you know, you couldn't have done by yourself. Yeah, I love that approach. [00:26:50] Dave Rosa: Yeah. [00:26:51] Lindsey Dinneen: Yeah, so okay. This is, this is marvelous. I really appreciate all of this so far. But I'm gonna pivot the conversation a little bit just for fun. So imagine that you were to be offered a million dollars to teach a master class on anything you want. It could be within your industry, but it doesn't have to be. What would you choose to teach? [00:27:13] Dave Rosa: Yeah, this this doesn't fall under maybe necessarily, you know, a a class that you would see in a, a normal curriculum. But, you know, I-- it's, it's something that I've tried to talk to my own children about, and that's teaching them about being thankful for what they have and also, you know, giving back to others that are less fortunate. I-- you know, there's a saying that, that "comparison i- is the thief of joy." You know, the-- I, I think the human race in itself just has a way of always dwelling on, like, what we don't have as opposed to being, you know, thankful to God for all that we do have. And I, and I, I, you know, I, I really think that o- one of the things that I've tried to instill in, in, you know, my, my children, and now they're all grown, is you gotta be grateful for what, what you have, but you gotta find ways to find common ground with people and, and be sure to give back to others that, you know, haven't been as fortunate as you. I, I think that's, you know, what this world should be more focused on than, you know, all, all you hear about today is what we don't agree with and why this side or that political party, you know, is ruining the world. I think if we all focused a lot more of our energy on helping others you know, the, the world would be and this'll sound cliché, a much better place to live in. So if I could teach a course on instilling thankfulness and and the importance of helping others, that's what I would do [00:28:49] Lindsey Dinneen: Yeah. No, that I couldn't agree more. Gratitude and giving back are, are key and, and the world needs more of it, so I love that idea of a masterclass for sure. And how do you wish to be remembered after you leave this world? [00:29:06] Dave Rosa: Yeah, it's-- it kind of goes back to, you know, what my dad said to me, and that was you know, as, as a, a youngster and, and that is, you know, my, my passion and interest to really help others. Yeah, that sums it up the best. [00:29:23] Lindsey Dinneen: Yeah, absolutely. Okay, and final question: What is one thing that makes you smile every time you see or think about it? [00:29:33] Dave Rosa: I, I would say you know, there, there are people that will doubt you and put you down in your career and tell you why, you know, you'll never do this or you'll never do that. And I can honestly say I never thought, you know, I would ever stand in Nasdaq, you know, on Wall Street and take a company public. And, you know, the, the one thing I, I do kind of cherish is I've been able to do this twice, but the first time I remember standing on the stage before the activity started at Nasdaq and one of the people in the company said to me, they said like, "You know, you just had this smile, you know, on your face. You know, it looked like you were thinking of something." And I said, "Yeah, you know, I, I was thinking about all those times that people told me that, you know, I, you know, I would never be successful in my career," and you can define success in different ways, but it, it kind of made me feel good. It was the first time I think I really felt, you know, proud of myself that, "Wow, you know, I'm, I'm one of a very small percentage of people that have been fortunate enough to, to actually you know, take a company public." So, it always makes me smile. [00:30:52] Lindsey Dinneen: Yeah. Yeah, absolutely. Great answer, and that, that's a really cool moment to reflect back on. Well, Dave, this has been a great conversation. I so appreciate your willingness to, to talk with me today, but also to share about the, the incredible work that your company is doing and your heart for helping people from the very beginning of your childhood, and obviously a huge passion of yours throughout your life. And we are so honored to be making a donation on your behalf as a thank you for your time today to Opportunity International, which works to end global poverty by creating and sustaining jobs while also providing small business loans, savings, insurance, and training to more than 14 million people in the developing world. So thank you so much for choosing that organization to support, and thank you for everything that you're doing to change lives for a better world. [00:31:47] Dave Rosa: Well, thanks for having me on the show as well. [00:31:49] Lindsey Dinneen: Of course. [00:31:51] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

In this episode of Medsider Radio, we sat down with David Veino, President and CEO of Neuros Medical.Neuros is commercializing the FDA-approved Altius Direct Electrical Nerve Stimulation System for chronic post-amputation pain.Before Neuros, David held senior commercial leadership roles at Cardiovascular Systems (CSI) and Stryker, and helped grow CSI's coronary and peripheral business from approximately $50 million to more than $250 million in annual revenue while leading key amputation-prevention initiatives. He also serves as a private equity advisor with Sectoral Asset Management. In this interview, David discusses how commercialization begins by mapping the patient journey upstream, what it takes to generate gold-standard clinical evidence for a novel therapy, how investors assess scalable medtech businesses, and how to build an investor pitch that earns the next meeting.  Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with David Veino, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:02) - David's 30-year medtech journey from cardiovascular devices to leading Neuros (04:38) - How Neuros is treating chronic post-amputation pain with on-demand neuromodulation (11:08) - Why Neuros completely changed its strategy halfway through the pivotal trial (15:36) - Why commercialization starts with referral pathways, not end-users (18:09) - How prosthetists became one of Neuros' most important referral sources (26:11) - What it takes to generate gold-standard clinical evidence for a first-of-its-kind therapy (37:41) - Building an investor pitch that earns the next meeting (41:42) - What gets David excited enough to invest in a medtech company

Healthcare professionals experience rates of burnout, depression, anxiety and other mental and emotional health challenges that often exceed those of the general population. Yet many clinicians never seek support due to stigma, concerns about confidentiality, logistical barriers, or fear of professional repercussions. As a result, many continue caring for others while silently struggling themselves.During the COVID-19 pandemic, Dr. Daniel Saddawi-Konefka founded the Emotional PPE Project to help address these challenges by connecting healthcare workers with mental health professionals willing to provide confidential, pro bono support. What began as an immediate response to an unprecedented crisis has grown into a broader effort to reduce barriers to care while advocating for lasting cultural and systemic change across healthcare.In this episode of Caring Greatly, Daniel joins Liz to discuss why he intentionally talks about both mental and emotional health, the three primary barriers that prevent healthcare professionals from seeking care, and why solving the problem requires more than resilience training. They also explore the role leaders play in shaping organizational culture, the importance of modeling vulnerability, and the policy, educational, and organizational changes needed to create healthcare environments where seeking support is viewed as a sign of strength rather than weakness.Dr. Daniel Saddawi-Konefka is a physician, researcher, and founder of the Emotional PPE Project. He is a leader who cares greatly.The views and opinions expressed in this podcast are those of the speakers and do not necessarily reflect the views or positions of Stryker. The provided resources may contain links to external websites or third-party content. We do not endorse, control or assume any responsibility for the accuracy, relevance, legality or quality of the information found on these external sites.

What if the next major advance in ENT surgery isn't a new instrument, but a better-integrated operating room? In this episode of the BackTable ENT & Allergy Podcast, Cleveland Clinic rhinologist and skull base surgeon Dr. Raj Sindwani joins Dr. Gopi Shah and Dr. Ashley Agan to discuss how reducing cognitive load, improving workflows, and creating a more efficient OR environment can enhance the surgical experience. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by Strykerhttps://www.stryker.com/us/en/ent.html --- Timestamps 00:00 - Introduction03:50 - Where Surgery Happens: Choosing the Right Site for Service06:27 - Quality Safety And Throughput09:48 - Reducing Cognitive Load In Surgery15:34 - Building an Efficient OR Ecosystem And Culture23:06 - Tech Adoption and Team Training26:19 - Smarter Surgical Navigation and Augmented Reality37:02 - Navigation Accuracy, Registration, and Smart Coaching40:29 - Inside the Stryker RISE Platform49:55 - Integration Challenges and Voice-Control Safety56:36 - Surgical Ergonomics and Injury Prevention01:09:14 - The Future of Surgical Innovation and AI in the OR --- More about this episode Dr. Sindwani explores how minimizing unnecessary friction, improving team dynamics, and thoughtfully integrating technology can help surgical teams focus on what matters most: patient care. The conversation examines the operating room as an ecosystem where people, processes, and technology all contribute to patient outcomes. Dr. Sindwani shares strategies for reducing extrinsic cognitive load, including standardizing room setup, minimizing interruptions, and optimizing the surgical environment.He also discusses advances in sinus and skull base navigation, augmented reality guidance, and Stryker's RISE platform, highlighting how integrated technology can simplify workflow, improve ergonomics, and reduce distractions in the OR. Throughout the episode, Dr. Sindwani emphasizes the importance of thoughtful technology adoption, team collaboration, and designing the operating room of the future around safety, efficiency, and the needs of both patients and surgeons. --- Resources Dr. Raj Sindwanihttps://providers.clevelandclinic.org/provider/raj-sindwani/4268990 Stryker ENThttps://www.stryker.com/us/en/ent.html Stryker RISE Platformhttps://www.stryker.com/us/en/portfolios/medical-surgical-equipment/integration-and-connectivity/or-integration/rise.html Technological Advances in Sinus and Skull Base Surgery by Dr. Raj Sindwanihttps://www.oto.theclinics.com/article/S0030-6665(17)30050-6/fulltext Ergonomics in ENT Practice NIH Articlehttps://pmc.ncbi.nlm.nih.gov/articles/PMC11455805/ --- BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Want more from Stryker and Luba? Check out Heart Rocket and get in touch Website: www.heartrocket.com Book Strategy Call: www.heartrocket.com/consult YouTube: www.youtube.com/@heartrocket Email: admin@heartrocket.com Did you find this valuable and want some more? ✅ Join the Brojo community on Skool If you like this video, you'll get even more from the guys doing this work with me every week. Join the Brojo Skool community here: https://www.skool.com/brojo-the-integrity-army-6491/about ✅ Go deeper with the right course This video is a taste of the work I do with clients. For a full, step‑by‑step system on this exact topic, get the deep‑dive course here: https://www.udemy.com/course/healthy-boundaries-in-relationships-friendships-and-work/?referralCode=3232CBEFEF445C7F6DAB. ✅ Apply for a free coaching session If you're done being a “nice guy” and want direct help applying this to your life, you can apply for a free 1‑on‑1 coaching session with me here: https://theinspirationallifestyle.com/lets-talk/ ✅ More about Dan Munro… - I've coached over 200 clients since 2013. Prior to that I spent 7 years rehabilitating high‑risk criminals in the Department of Corrections. - I've published 4 non‑fiction books on confidence, valued living, and overcoming Nice Guy Syndrome. - I spent my first 25 years as a sufferer of Nice Guy Syndrome who struggled with confidence, dating, and meaning in life. I transformed myself with hard work, courageous actions, and a never-ending education in psychology, integrity and confidence. - I went from miserably single to creating a strong marriage and becoming a father. These videos are free, and they're also my marketing: if they help you and you want more, use the links above.

At this year's Medtech MVP, a panel of industry experts explored how robotics are changing healthcare beyond the operating room. Robotic technologies are being deployed across inpatient care, rehabilitation, logistics, and remote patient support. Moderated by Virginia L. Giddings of Edwards Lifesciences, the panel includes Amanda Baumann of Stryker; Nir Goldenberg of Mayo Clinic Ventures; Kate Jackson Hobbs of Intuitive; and Maggie Nixon of Capstan Medical. Together they discuss the workforce, financial, and reimbursement considerations shaping adoption and how AI advancement will affect the future of robotics. Medtech Talk Links:  Cambridge Healthtech Institute   Medtech Talk  Medtech MVP Edwards Lifesciences: Edwards Lifesciences Stryker: Stryker Mayo Clinic: Mayo Clinic Intuitive: Intuitive  Capstan Medical: Captstan Medical  

Stryker Peak by Wild Montana

HAPPY 250TH BIRTHDAY!!!!!   My distinguished guest today ran missions over the border from South Vietnam into the DMZ, North Vietnam, Laos and Cambodia all while part of MACV-SOG. This is a mere smidgen of his story and those he served with. Enjoy!! The YouTube version has a lot of edits in the video to help explain what John, Tilt, is talking about. Those include pictures and maps.

Army Veteran Manny Pasillas Lucio shares the combat story that changed his life forever.Born in Mexico and raised in California, Manny grew up navigating family tension, poverty, and the streets of Compton before deciding to join the Army after 9/11. After basic training at Fort Benning, he was sent to Fort Lewis, Washington, where he became part of a Stryker infantry unit and later joined a scout sniper platoon.In this episode of Urban Valor, Manny opens up about his deployment to Iraq, including missions in Mosul, Baghdad, Taji, and Baqubah. He describes small team missions, hunting high-value targets, taking fire, encountering IEDs, working alongside other units, and the daily fear that came with operating outside the wire.Manny also shares the devastating moment his Stryker was hit by an IED while returning to base. He woke up choking on smoke, heard screams around him, and later discovered his teammate Billy Ferris didn't survive the blast. That moment stayed with him long after Iraq.After coming home, Manny struggled with PTSD, anger, depression, suicidal thoughts, family separation, and the painful reality of trying to become a father while still carrying the war inside him. He talks about pulling a gun on his mother after being startled awake, snapping at family members, feeling lost after the military, and eventually using education, therapy, fatherhood, and veteran advocacy to rebuild his life.Chapters00:00 Waking Up After the IED Blast01:25 Manny's Childhood in Mexico02:48 Coming to the United States03:49 Growing Up in Compton08:08 Learning Independence as a Kid10:05 Wanting to Become a Soldier10:50 How 9/11 Changed Everything11:37 Trying to Join the Military14:04 Watching the Iraq Invasion Begin15:31 Leaving for Basic Training16:23 Arriving at Fort Benning18:44 Building Confidence in Basic Training22:11 Getting Sent to a Stryker Unit23:24 Joining 5-20 Infantry26:23 Becoming an RTO27:57 Learning From Hard NCOs32:19 Being Offered West Point32:58 Moving to Scout Sniper Platoon36:24 Deploying to Iraq37:22 Landing in Kuwait38:39 Arriving in Mosul40:17 Small Kill Team Missions41:11 First IED Strike in Iraq41:51 Hunting a High-Value Target43:30 Walking Outside the Wire44:51 Capturing the Target46:25 Moving From Mosul to Baghdad47:11 Searching for a Downed Pilot47:52 Taking Another IED Hit49:26 Billy Borrows Manny's Blanket51:09 Spotting an IED on the Road53:28 The Stryker Gets Hit54:16 Escaping the Crushed Vehicle56:08 Searching for Billy57:30 Evacuating the Wounded58:47 Sergeant Pucket's Words After the Blast59:18 Returning to Base in Shock1:01:15 The Loss of Billy Ferris1:05:04 Billy's Memorial1:06:14 Back to Combat Operations1:07:04 Working With CIA and Special Forces1:08:29 Testifying in the Green Zone1:11:05 Inside Saddam's Palace1:12:00 Arriving in Baqubah1:13:19 Taking Fire From All Sides1:14:47 Clearing the City1:15:13 The Scariest Missions of His Life1:17:20 Finding Iraqi Police With Mortars1:19:14 Ambush and Firefight1:20:38 Becoming Numb to Loss1:22:10 Fighting Al Qaeda in Baqubah1:23:34 Coming Home From Iraq1:25:22 Almost Going to Ranger Battalion1:26:02 Leaving the Army1:27:10 PTSD Hits at Home1:28:26 Snapping Around Family1:30:07 His Family Didn't Know What Was Happening1:34:12 Struggling in the Reserves1:36:19 Drinking, Trouble, and Feeling Invincible1:37:29 A Bad Experience at the VA1:40:42 His Daughter Saved His Life1:42:49 Using the GI Bill1:43:14 Studying Psychology to Understand PTSD1:44:53 “I Am Not My Mistakes”1:45:39 Breaking Cultural Cycles1:46:35 Becoming a Better Father1:47:20 Helping Veterans Today1:49:10 Reconnecting With Family1:51:20 Why Manny Puts Himself First Now1:52:02 Talking Honestly With His Daughter1:53:24 Advocating for Veterans and Families1:54:34 Manny's Message to Struggling Veterans

X2: X-Men United - Ep. 401 This week on Normies Like Us, we're diving into 2003's X2: X-Men United, the film that proved superhero movies could be bigger, darker, and better. Join us as we revisit Nightcrawler's legendary White House attack, Wolverine's mysterious past, Magneto's master plan, and the uneasy alliance between heroes and villains against the fanatical William Stryker. Grab your Cerebro helmet, watch out for adamantium claws, and join the mutant revolution because the future is now on Normies Like Us! To Me, My Normies Insta @Normies_Like_Us https://www.instagram.com/normies_like_us/ @jacob https://www.instagram.com/_j__a___c___o__b_ @Mike_Has_Insta https://www.instagram.com/mike_has_insta/ https://letterboxd.com/BabblingBrooksy/ https://letterboxd.com/hobbes72/ https://letterboxd.com/mikejromans/

Turning activewear into technology that actually supports how you move — that's the magic

In the latest RAMS Ask a Chair podcast, host Eileen Williams talks with Dr. John Hoyle to discuss mentorship, simulation, interdisciplinary collaboration, and the value of learning from experts in other industries.

Today's episode is a continuation of the Academy Series of Transforming Healthcare, and we're honored to welcome Katherine Truppi. Katherine is the President of Joint Replacement at Stryker, where she leads one of the company's largest business units. She has spent more than 20 years at Stryker, building deep experience across endoscopy, marketing, sales, and general management, including leadership roles in the U.S. and Europe.    Katherine joins us for a wide-ranging conversation on leadership, culture, and the future of healthcare. She shares a candid look at leadership, growth, and the realities of driving innovation inside a major healthcare organization. The conversation focuses on building strong teams and making decisions that drive real impact. Stay tuned for more from our Academy Series.

Social engineering has a reputation problem. Most people hear the term and think phishing, scams, and threat actors. AJ Nash and guest Ashley Stryker push back on that framing in this episode of Unspoken Security. The conversation opens by defining social engineering on its own terms: the act of understanding how people work and using that knowledge to get them to take a specific action. The technique itself is neutral. What determines whether it crosses a line is motive and outcome.From there, the conversation moves into the mechanics. Urgency is one of the most effective social engineering tools threat actors use because time pressure cuts off critical thinking. Stryker argues that the real defense is not training people to recognize a specific type of phish. It is training them to pause before acting on anything that creates pressure around money or security. She also makes a pointed case against security awareness programs that raise awareness without giving employees something concrete to do. Information alone does not change behavior. Action does.The episode closes with the show's signature "unspoken" segment, where Stryker shares the full story behind why she goes by her last name. It turns out there are several reasons, including a divorce, an ex-husband with the same first name, and a deliberate operational security strategy she has used since entering the cybersecurity field.Send us Fan MailSupport the show

Send us an inquiry through a text message here!Buy your tickets here: https://www.axs.com/events/1451690/the-veterinary-roundtable-ticketsSaddle up for The Veterinary Roundtable LIVE at Cannery Hall — the ultimate western-themed night out for veterinary professionals at WVC Nashville 2026! Hosted by Dr. Adam Christman with special guests Sarah Parsons and Walter Brown, this one-of-a-kind live experience brings together everything you love about the veterinary community: laughs, hot topics, friendly competition, cocktails, and unforgettable moments with your clinic crew.Expect a high-energy evening featuring:A LIVE Veterinary Roundtable podcast episodeAn interactive game show packed with surprisesFree food and veterinary-themed cocktailsThousands of dollars in prizes and giveawaysDust off your boots, grab your cowboy hat, and join us at Cannery Hall for a night of connection, celebration, and pure veterinary chaos in the best way possible.This event is proudly sponsored by Solensia™, Librela™, CoVet, Midmark, Stryker, and The Farmer's Dog.

What does it take to engineer a machine capable of dominating asphalt, gravel, rally stages, hill climbs and off-road terrain?In this episode of EPARTRADE's Race Industry Now, Stryker Race Cars Co-Founders John Annunziata and Cole Powelson take viewers deep inside the engineering philosophy, drivetrain strategy and motorsports experience behind the Stryker platform.From Pikes Peak inspiration to advanced AWD integration, lightweight chassis engineering and a competition-proven Rotax turbocharged powertrain, this episode explores how Stryker Race Cars is redefining the modern multi-purpose performance vehicle.Topics covered include:• AWD and rear-wheel-drive switchable performance• Rally and off-road chassis engineering• Rotax turbocharged 3-cylinder engine technology• 7-speed dual-clutch transmission integration• Baja 1000 and King of the Hammers durability insights• Pikes Peak development influence• Lightweight vehicle dynamics and driver engagement• Multi-surface motorsports engineering philosophyFeaturing:John Annunziata – Co-Founder, Stryker Race CarsCole Powelson – Co-Founder, Stryker Race CarsHosted by Brad Gillie from SiriusXM, Ch. 90, Late Shift.

In this episode of Medsider Radio, we sat down with Antony Odell, co-founder and CEO of Echopoint Medical.Echopoint is a London-based UCL spinout developing iKOr, an optical microcatheter for coronary diagnostics.Antony brings over 30 years of medtech experience across Johnson & Johnson, Fresenius, and Stryker, before transitioning into startups as CEO of Tayside Flow Technologies and Tissue Regenix. He holds a BSc in Physiology and Biochemistry.In this interview, Antony discusses translating academic IP into a commercial device, choosing early clinical sites to balance speed and learning, managing non-dilutive funding as a long-term discipline, and outlines the most important responsibilities of an early-stage medtech CEO.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Antony Odell, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:06) - How Antony's career centered on translating clinical insights into commercial reality (05:54) - What Echopoint's iKOr does, and why 40% of cath lab patients leave without a diagnosis (12:13) - How Echopoint landed its first U.S. clinical site, and what that means for the company (13:48) - What to assess before spinning out an academic idea, and why clinician input is the first real test (20:14) - Why Echopoint chose Barts over typical sites for its first-in-human study (22:58) - How getting too close to one clinical site can lead to dangerous groupthink (30:54) - Why non-dilutive funding belongs on the board agenda permanently (39:54) - How CEOs should manage boards, control information flow, and avoid becoming a “glorified note-taker”

Spencer Jones, Founder of XO Medtech and MedtechVendors.com, shares how frontline nursing experiences led him to patent vascular access innovations and ultimately take devices from idea to FDA clearance and product launch. Spencer walks through learning business fundamentals through accelerators, raising early funding, and building sales and distribution networks, then explains why launching a digital-first, AI-native ecosystem has enabled faster, leaner execution than traditional medtech pathways. Spencer also discusses leadership, clear communication, and why AI adoption is essential to accelerate and de-risk early-stage medtech.  Guest links: https://www.linkedin.com/in/medtech-innovation/ | www.xomedtech.com | https://medtechvendors.com/  Charity supported: Polaris Project Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 080 - Spencer Jones [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome to the show Spencer Jones. Spencer is the founder at XO Medtech and MedTechvendors.com. He is an RN, MedTech entrepreneur with 12 years of med device leadership. He's a two time med device CEO with 10 plus patents under his belt and has taken devices from idea to FDA clearance and product launch. Spencer has built sales and distribution networks, led product development teams, and raised over 10 million in VC and Angel Capital. Spencer founded XO MedTech in 2024 to create a digital first medtech ecosystem, deploy AI native tools for medtech operators through medtechvendors.com and cultivate the next generation of medtech innovators. All right, Spencer, welcome to the podcast. Thanks for being here. [00:01:43] Spencer Jones: Thank you for having me, Lindsey. I'm very, very excited to be here. Like it's, it's always more fun to be a guest than it is to host the pod, so absolutely thrilled to be a guest on the pod. Thank you for having me. [00:01:54] Lindsey Dinneen: Of course. Absolutely. Well, yeah, let's just, if you won't, don't mind just sharing a little bit about yourself, your background and what led you to medtech. [00:02:04] Spencer Jones: Yeah. Born and raised in Arkansas. I've lived, I traveled a ton and lived in Memphis and whatnot, but grew up in a healthcare household. Dad did anesthesia for, what was it, 36 years or something at the same place. So I thought I was gonna be a CRNA, like actually started pre-med. Took chemistry my freshman year while I was, you know, it was just, I got a C and I was like, maybe, maybe med school's not for me. But but anyways, did the nursing school thing, got out, started working, pretty quickly, knew if you've ever spent any amount of time in frontline healthcare, you just kind of get, it's like a barrage of things that suck. It's just, especially nursing, the devices you're using are commoditized. Like just the workflows are bad. You know, people, it's, healthcare is very broken. Every, it's no secret. Everybody says that. Everybody knows that. So anyways, I noticed pretty quickly that hey, like why isn't this better? Why can't this be like this? And, you know, kind of had that mindset. And before I could even go through like critical care enough to apply to a CRNA school, ended up patenting some devices in the vascular access space. Really leveraged accelerator programs and the entrepreneurial support organizations that were in my area, in my region to, I call it that get that dirt money, which is like the before the seed, you know, your pre kind of, your pre-seed /seed you know, before the pre-seed money. And, and also like the business training, right? Like I wasn't formally trained on business stuff like that. So did that. Did the venture capital hamster wheel a little bit, took a, you know, device through class two de novo clearance. Was doing ride-alongs training, sales reps, doing marketing stuff, you know, managing our ip, managing clinical you know, 300 patient RCT that we had to do in the middle of COVID, launched the product and then past couple years, I left, left that company in 2022. Products still on the market and they got, you know, clearance in, in Europe now and et cetera, et cetera. But just been working more in laparoscopic spine or laparoscopic surgery orthopedic spine and then doing some like consulting projects and, and things like that. And then yeah, XO Medtech and Medtech Vendors that's been. You know, for the past two years, like a big focus. And I know we're gonna talk more about that, but yeah. So it's just been, it's been a great journey. Medtech is one of my --I love it and hate it at the same time, but I wouldn't wanna be doing anything else, frankly. So. [00:04:17] Lindsey Dinneen: Awesome. That's a great intro. Okay. You were, I really, I enjoyed how you sort of went straight from okay, so, so "I, you know, started the career, started in the industry, and then I, I, you know, got a bunch of patents." What were the ideas for the patents? Where did those come from? If we could just go back, how did that, what was that inspiration like? [00:04:39] Spencer Jones: Yeah. So I was night shift, med-surg, big, pretty big hospital in Little Rock. It was like one of the, one of the bigger ones in Little Rock, St. Vincent's, which is like CHI, St. Vincent, et cetera. And like one of my patients --well the, the very first one was a dual lumen peripheral IV. A patient has a peripheral IV in, I need to get a blood draw. They're like, "Go stick his other arm." I'm like, "Why can't we get it out of his, you know, IV that's in his, that's in his forearm?" And, and they were like, "Well, you, you know, you don't want to contaminate, you know, the thing." And I was like, "Oh, okay. That kind of makes sense." And I was like, well, PICC lines have two lumens. So you know, I was like, why couldn't, you know, why couldn't we just have a second lumen on, you know? And I was like, do those exist? And they didn't really exist. There was kind of one that existed, but it was more of like a longer extended dwell peripheral and you know, you kind of needed ultrasound to place it. You didn't really place, you know, normal nurses on the floor weren't gonna place it. And so I kind of, that one was just sheer-- I experienced something that I was like, "Dude, you're kidding me. There's gotta be a better way to do this." You know what I mean? And you know, kind of similar approach in that one. We, you know, that was the very first one so I was like doing these drawings on note cards and then like meeting with a patent attorney and I was like, did that provisional filing and wrote the patent myself and the claims and all this stuff. And the guy thought I was like, just " Okay, yeah, I'll, I'll file the provisional for you, bro, whatever." Filed the provisional, you know, ended up like going to a different attorney 'cause that guy was kind of just not taking me seriously. And so, ended up going to a different person, filed a non-pro provisional, started raising all this money, and that original attorney reached out later, was like, "Oh, so glad, glad to see blah, blah, blah." I was like, "Yeah, yeah, whatever." But then the second one, I, which was Safe Break Vascular, had the, it's kind of similar. Patient was like, had patients pulling out their IVs, pulling out lines, you know, and it's a million things. It's, it's walkie talkie, so like Alzheimer's, dementia, memory care type stuff. You, it's TBIs, it's agitation, sundowners. It's, you're coming off medication, you're drowsy, you forget, you're hooked up. You need to go to the bathroom. You trip on it. The nurse trips on the tubing. There's like a million reasons how, you know. Where mechanical force can get applied to an IV line. And same thing, I was just like, man, like this, it, it feels holding on for dear life is like the wrong approach because skin is only so strong. You get skin tears. Adhesives, you only want them to be so, you know, so, so strong. And it just, you know, it, wrapping it up, then you can't assess the site, you can get infiltration. So it didn't feel like any of the options we had were great. That one, I started to do patent research literally on the floor at the hospital. Like that night. I was like, I, 'cause I knew enough then found someone that had patented it. Like same exact concept. It was a nurse. And design was bad. Like the design, it had springs in it and it was just like not manufacturable and not a good design, but there were like conceptually it was like spot on. And then there were some elements of it that I was like, this would be very useful to have if I was gonna like actually do this. So me and somebody I'd met, and in accelerator program, we bought the patent from 'em for 20 grand which was a steal of a deal. It was like 10K up front, 10K after 18 months. And yeah. And then we turned around and raised a, you know, million dollar seed round within like, within nine months after acquiring the patent, got into an accelerator, ZeroTo510, shout out to them. But acquired the patent in February. Got it, or March, got into ZeroTo510, April. Went there in May, closed our seed round of a million in December, so it was like a nine month, yeah, ordeal. [00:08:03] Lindsey Dinneen: Wow. That's okay. That's awesome. I love the story. I love the fact that it was from boots on the ground going, "Okay, I see this problem. There's gotta be a better solution." That's super cool. So. All right, so you have these patents, you're going and you're working with accelerators. Can you tell us a little bit about what that experience was like, especially since you mentioned, you know, you didn't necessarily have the business background, so there was, there was probably a bit of a learning curve to that whole, you know, how do you get your idea from your, your note card drawing to commercialization. So I'd just love to hear about your experience. [00:08:35] Spencer Jones: Yeah. The, so I did one accelerator before ZeroTo510. It, I basically did two within about a year, a year of each other. It was like back to back to back. But the first one I did, it was industry agnostic. So it was just a lot of like mentorship and lean canvas startup methodology kind of business practice stuff like accounting 101, you know, building financial forecasts and models and like all of that stuff. So I really learned a ton about kind of just non device specific stuff there. Obviously I was learning a ton about device stuff along the way, but then once I got to ZeroTo510, that's when things kind of like really, you know-- and I had, I had won, I won that first accelerator. It was like a competition, and so I had 150K. And I was like, "Oh wow. So maybe, maybe this is gonna be a career path," 'cause I was still working full-time as a nurse and then I got into the second one. ZeroTo510 was amazing. Allan Daisley was running it. James Bell was like the co-director, I think, and it was like bootcamp. It was like, you know, 8:00 AM to 5:00 PM. It was like sessions and mentor hours and office hours and " Alright, we're done with that. You guys work on this for an hour and a half, we're gonna come back and talk about like the finished product and you better have it done." You know what I mean? And it was every day. I lived up at this building. It was amazing sponge mode. You know, it was one of those environments where you're just like constantly soaking it in and learning and learning and like you can feel your brain expanding like every day. You know, you wake up excited. And that one was amazing. Met a ton of people that I still work with today. You know, met my co-founder at XO Medtech. Met him at that accelerator. But yeah, it was just, that one was amazing. I was like, life changing. Came back from that and I was like, "This is what I was meant to do." I felt like I you know, found my calling. And so, yeah, shout out to the people there that you know, we're a part of that. [00:10:20] Lindsey Dinneen: Love it. Excellent. So, okay, so you found your co-founder for XO Medtech, and this is great because I wanted to dive into that. So, so you've, you've now successfully taken like several products to market and of course you have a lot of other great industry experience. What was, how was it different starting XO Medtech and Medtech Vendors than perhaps other things that you'd done in the past? [00:10:47] Spencer Jones: Yeah. You know, I'm gonna say it was way easier just to be honest. I mean, I mean, you know, I think we, we were doing a lot. We started building XO Medtech in 2022, 2023, and at that time a lot of it was like, it was really focused on the community and the training platform and the resources and kind of all the videos and things that we put in there. Which I still like to this day, will stand on it, that like there, if you're an early stage innovator and you're, you wanna like kind of internally like level yourself up, right? There's no better place than like XO Medtech and the training and inside there to do that, right? But, but yeah, it was we started doing it at a time when AI was starting to become, like Chat GBT, what was it, four was coming out or whatever. So we started it kind of before the wave and then as we were continuing to build it in like 2023 which was like the meat of us building it. It was like kind of starting to become more of a thing, but we still weren't really using it that much. But then as we really went into kind of like launch and growth mode in 2024, it was just like a huge tailwind and like being able and, and it continues to be. But like not having to raise, you know, three, four, $5 million to get a business off the ground and to get to a point where you can start selling something is just incredible. I mean, like we are, we are so agile and can move so quickly and, you know, we don't have any investors. We don't want any investors. So like our speed at which we can move is unbelievable. And coming from somewhere where it's " Oh, you wanna put out something for marketing? Route it through the quality management system and like maybe it goes out in two weeks." You know, we can go from like idea to feature in a week. You know what I mean, you know, let alone like idea to like press release, right? That's 10 minutes if we want to be, right? So really it's just, it's a lot easier and this takes nothing away. There's some incredibly rewarding parts of kind of my, like my medtech journey and stuff like that, like the day we got FDA clearance and, and X, Y, and z whatever date, you know, first sale and getting our first GPO contract. But it's, it's definitely more I would say day to day, just like the exhilarating agility, excitement type stuff that you like, don't really get with with me. And I'm not, I'm not taking anything away from, I'm still a medtech person through and through and I'm sure at some at some point I'll you know, do another device. We're developing another device at Lapovations, so, in combo spine. So my hands are still in it, but I love, love, love what we do at XO Medtech. It's so much fun. [00:13:11] Lindsey Dinneen: Awesome. Well, I love hearing that. So tell us a little bit about both XO Medtech and Medtech Vendors and yeah, their, their focuses. [00:13:21] Spencer Jones: Yeah. So I think, you know, like I said, we started XO Medtech and it's, it's a online community. So think like Skool, like S-K-O-O-L School or Circle, or there's some other Mighty Networks, like one of the-- we use Circle-- but you know, it's whether you're ideation or just like curious about medtech all the way through like series A really, you know, we've got, you know, there's community feed, people are posting. I mean, we posted you know, Project Medtech, you know, event stuff, discounts a lot of exclusive stuff where, I think we added, it was like three or $4,000 worth of discounts. Like just for being like once you join XO Medtech. But then there's that primary feed people, it's like a massive exchange of value and it's it's not like LinkedIn. There's no promotion. Like we base, we will take your post down if you're like nakedly promoting your own stuff or your services, whatever. The whole point of it is to be massive exchange of value. So you know, "Hey, we did some like really cool testing, ETO sterilization testing on coil tubing to see how it retained its memory. Here's what we found, your pictures," you know what I mean? Just stuff like that where it's like kind of giving people behind the, behind the curtain peaks at your own organizations or that kind of, those, those moments of alpha, those nuggets that you've found and just sharing it so you can have you know, and they're doing the same and everybody's better for it. But then we have a training course and then some other like mini courses, probably a couple dozen downloadable resources. So these are like, you know, prebuilt, proformas, budget forecasts, you know, IP stuff, due diligence type stuff, like stuff to help you with, get your data room beef, you know, beefed up and looking good. And we do videos. There's some live events every now and then. So, so that was very focused on the founder side, you know what I mean, like the entrepreneur side. We, you know, my co-founder used to run a med device, venture studio, so like doing like business engineering, business development, engineering, you know, kind of market related stuff for like early stage, largely like clinician and inventors and stuff like that. He used to run a, a, a group that did that. And we knew we wanted to kind of start to do more offerings that kind of for that side of the table, like the CDMO contract manufacturer design and development group side of the table. So we launched, we started building MedTechVendors.com and launched it in 2025, February, 2025. And then did kinda a relaunch with adding some like agentic AI features in I think at the end of the summer last year. But it, but at its core, I always say this analogy, it's like Angie's List, right? You know, Angie's List, what do they do? Well, it connects people with local pros. Allows them to like, evaluate, engage them really easily, you know, get, get their stuff done quickly from trusted people. You know what I mean? So we have the same approach. We help device teams, and that could be device teams at large, medium, small, or startup organizations or tech transfer offices, whoever we help those device teams find, evaluate, and engage contract manufacturers, CDMOs testing facilities, design and development groups, one man band engineers, whatever through the platform. We have an an ag agentic AI chat. So like it'll ask you questions about your device. It'll start recommending, "Hey, do you need this? Do you need these types of services? Are you looking for this type of vendor? This type of vendor?" It pre-populates forms. It generates matches for you. You can review each vendor's profile, one click get email intros or request quotes, and we're adding some some really cool additional features around some different like skills that you can run. So, think like a reimbursement skill or market a, you know, different predicate device selection skill, whatever. And so those are all gonna be like linked up to the to this kind of AI agent. I don't wanna say too much 'cause we're still building it. I'm like really excited about, but there's other things that we're adding to it. The ability to do quote, visualization you know, and trying to make it kind of a, you know, a home away from home, a hub where you can track execution, get things done, engage vendors, and kind of evolve it more laterally in kind of the lifecycle journey. Not just " Hey, I'm looking for a vendor," 'cause that's a very acute point in time in a, you know, in a person's journey. But trying to expand it out to say the period of time when you're doing X and Y and Z and looking for a vendor so we can get some really was sticky, more sticky use and add more value. So, that was that. And we've started really focusing on some more like intimate, I would say, engagements with CDMOs contract manufacturers focused on giving their sales and marketing teams massive, massive leverage using AI and ai, AI native tools. [00:17:35] Lindsey Dinneen: Awesome. That's really cool. Yeah. Okay, so going back a little bit to the, to XO Medtech, I know you know you, you mentioned that there's a lot of resources available, but one of the things that I think is super cool, and I would love if you just share a little bit more about this, is you have a course that-- i don't remember the name off the top of my head-- but it's basically sort of Medtech Innovation 101. It's, I think... [00:18:00] Spencer Jones: Yeah, The Playbook. [00:18:00] Lindsey Dinneen: Call it like-- The Playbook! And you call it like the MBA for somebody who needs to learn. So can you just share the value of that and sort of what, what made you go, "Okay. I have, you know, the expertise in all these different areas enough to be able to share the journey from start to finish." [00:18:19] Spencer Jones: Yeah, absolutely. I think like the, the value there partially comes-- I mean, I think speaking about the value, you gotta speak about kind of like why there was a gap there, like how it, why it didn't exist, whatever. There's just a lot of really bad content in medtech. You know, there's a lot of stuff that reads I mean, there's guidance documents, you know, ISO and this and that. Like those are tough reads, right? And then, you know, the, the content around " "here's how you really fundamentally apply these guidance documents and here's how all this fits together." And it just felt like everything was I don't know what the opposite of like inside baseball is, right? Like that kind of " Hey, here's what you really need to know." Whatever the opposite of that is, is how medtech content felt like to me everywhere. It was just like polished press releases, really, like consulting speak. You know, "You gotta be strategic with your analysis." It's okay "You know, you know, you gotta find your champions." "How do I find them? What do I tell them? You know, how do I engage them?" So it was just, that was the big gap. So I think the value, what we tried to do with The Playbook was, you know, give, like I said, pre-seed all the way through Series A, the right information, like the right depth, on the right topics in the right order with the right assets, so resources, downloads, all that stuff along the way so that you can go cradle to grave on this, basically be a novice, or we've had people that have launched products and gone through it and they were like, "Holy crap, I wish I would've had this five years ago." But the whole idea is to basically not make you a supreme expert on any one of those topics. There's 46 different lessons, 47, and like you can get through each one in probably 20 minutes, right, 15 minutes. But not to make you an expert on each individual topic, but to give you like a dangerous level of information on any one, and then make you able to dive deeper on any of them, you know, very quickly and easily. So like when you meet with your, you know, a regulatory consultant or an IP attorney, or go down the list, you are not, they're not saying words you don't know for the most part. You're not paying them $300 an hour or $500 an hour to educate you on definitions and concepts. Right? You're, you're applying principles and evaluating strategy versus " What's that again? Like, how does this, what's the timeline for that?" 'Cause that you know, that's just not good for anybody. You know, so, so that, that's kinda the main, the main value prop thrust of it. And I just, I frankly didn't think it existed, but proof's in the pudding. Like we've sold it to accelerator programs, we've sold it to hospital, you know, innovation departments. We've sold it to incubators, like trade associations that have like their like kind of innovation arms. It works. Like when people do it, it works. It's funny-- we can talk about this too-- but like the, you can lead a horse to water thing. It's funny how many people say they want to be entrepreneurs and say they wanna be innovators and really they just want to just yap. And they don't actually wanna put the time in. I'm telling you, it's like crazy how many, you know, fake entrepreneurs there are out there. But it's okay. It's okay. You know, like there has to be, I think there needs to be some cleaving or weaning or calving of the herd to some degree because we've got, I don't know, and maybe we need to develop 'em more, but it's, it is frustrating seeing it firsthand when it's like "You have a really cool device, but you are so uninvestible and you have no interest in being coachable that it just hurts me." [00:21:30] Lindsey Dinneen: Oh yeah, absolutely. No, I love that you've done that resource and yes, super excited to see hopefully a lot of innovation actually happen and be successful as a result of that. So with, you know, okay, so you have, you have this community now and I'm wondering if there are any moments that kind of stand out to you, maybe as you've built the company, also Medtech Vendors that kind of enforce, "Wow, I am, I am in the right place at the right time." [00:22:00] Spencer Jones: You know, I definitely-- you know, it's, it's, it's really, there's not, I would say, any huge singular moments. I mean, we've had people like get business from coming on the XO Medtech podcast. You know, we've had people meet new clients, new strategic partners type stuff, like in the XO Medtech community. I mean, I've made a ton of friends in the XO Medtech community, people that I talk to you know, every, every week or two you know, Brad Shirley, I'll mention him. He's fantastic. And like I've learned from him, he's learned from me. We've both learned stuff from the community. I, I, I really do think it's though, it's like it's, you know, those-- whether it's a LinkedIn DM or you know, somebody messaging me in XO and they're like, "Hey, I just went through this lesson. It was like, so good. You know, blah, blah, blah." And I think those little things honestly like power me, power me up, give me juice, give me energy. You know, and, and like reading, we, we did a ton of, I mean we probably got 30 people that did kind of like a pre- and post- assessment and they gave their feedback on The Playbook so we could refine it like as we were, you know, after launch and all that stuff 'cause we're constantly trying to improve it. And have reading the testimonials and people just being like, yeah, like "This is, this is killer." People that are brand new, people that have been in the industry for 20 years that went through it. I think so, I think, I think it's kinda like a myriad of those things. I would say some of the stuff on-- and that's on the XO Medtech -- I think some of the stuff on the Medtech Vendor side and what we're doing with, you know, kind of campaigns and the tools that we're developing and the work that we're doing there, like we are fully an AI native organization. Like it, like we, it there is just not at all like a significant amount of people in medtech using AI to like actually do not in their products. I don't care about that. Like I'm talking about like in their day-to-day operations and, and whatnot and like we're trying to change that. And so like in that respect, like we will come out with things, you know, release features, release products, build custom tools for CDMOs and you know, the looks on their faces and like how amazed that they are at X, Y, and Z. And sometimes it's like stuff where it's hey, I'm like building them a just showing them how to do something with not even a tool that we built and like they're blown away. And anyways, all of that stuff, I feel like, man, like this is where I'm supposed to be because like. We, we've gotta make MedTech a more attractive investment opportunity. We've gotta compress the development cycles and the cost to develop and the time to develop and get things to market. You know, and I look at AI drug discovery for the pharma world as like a huge way that that's happening. But we have to have that similar type of like, when you to engage with this, it will be good for our ecosystem and industry as a whole, becoming more investible, becoming more cash efficient and all that stuff because you've seen other sectors, you know, software is taking money from early stage medtech, like nobody's business. You know, people are investing AI and you know, I just looked at the annual report from like HSBC, the Venture Report, and like me, early stage medtech funding continues to be down. You know what I mean? So we just gotta do something like, I, I feel like it's an existential, it's an existential issue for early stage medtech to get better at being scrappy and using AI. [00:25:03] Lindsey Dinneen: And there's so much opportunity there. Yeah, I love that you're helping to promote that. So you've gotten to lead a number of different companies now and through very challenging milestones. And so I'm curious, how has your own leadership philosophy developed over the course of your career so far? [00:25:24] Spencer Jones: Oh, what a good question. You know, I, I hate to say this, but I've almost gotten more cynical, you know. [00:25:30] Lindsey Dinneen: Okay. [00:25:31] Spencer Jones: Well, and it, it's, it's like I try to be very protective of my time and like protective of the time of the people that I work with, right. You know, and that doesn't mean I'm not willing to like go the extra mile and whatnot, but I think it's about respecting people's time. Right? And, and you know, I think honestly my leadership philosophy, I think a lot of it revolves around just like incredibly clear communication and like staying above the fray. No riff-raff, just just executing and moving fast and like keeping expectations really high, because I feel like when you've got complacency, you know, at the top, it just, it like doubles every rung of the ladder lower that you go in the org chart or whatever. You know, so I think like pace, you know, pace and hyper clear communication, like no subversive or passive aggressive or anything. It's just like straight up, like I'll just exactly tell you if I wasn't happy with something or whatever, but I just, I don't know, like I feel, I feel like you know, leadership style too, like I think, I think it, so much of it boils down to communication for me. It's just like really, really clearly communicating and like making sure that people understand what good work looks like and what a, them doing a good job looks like, and where... Yeah, I think, I think being clear about expectations, really clearly communicating those expectations around like work product, what it should look like, how fast it should get done, how many updates I need, or how many questions I expect to get as you're doing this, what resources I expect you to expend and explore before you come to me with something you could Google. Like all of that stuff, but honestly, I, it, it's kind of a tough question thinking in like the more immediate past, just because I feel like there's been such like, almost like a flattening of org charts, frankly, with the way that we're using technology and AI these days where I feel like in the companies I'm operating in right now, like it's mainly just principles and like lower level stuff, like we're either delegating to AI agents or delegating to like VAs that are in a different country or something, you know what I mean? And, and so there's just been a big flattening. You know, seven years ago, six years ago, I was managing, you know, new grads outta college, two or three at a time, and, you know, having to like, have these kind of like, you know, like brotherly, you know, like talks with, you know, these types of things, " Hey, like you really gotta do this" and like coaching and stuff like that, i, you know, there's a, we have to have that stuff. I'm just not in, in organization and honestly, the organizations I'm in right now in startup world I just feel I don't know. Like I, I feel like we're, I haven't seen that and I, I know a lot of organizations that are small and nimble and whatever, and I feel like the org charts are getting real flat in terms of like people that are getting managed, you know, it's a lot of agents getting managed, frankly. [00:28:21] Lindsey Dinneen: Yeah. Yeah, yeah. Interesting. Yeah, that, that's a really interesting insight too. But I really do think that to your point of coaching and mentorship and how much of a difference that makes, but especially, I was just on this conversation earlier today of the critical importance I feel that there is about establishing expectations across the board, whether it's your clients, your employees, your coworkers, just making sure that everybody's on the same page is such a critical aspect of, of setting yourself up for success. So yeah, I love that you touched on that 'cause like I said, literally earlier today. [00:29:00] Spencer Jones: Yeah. And, and can I, can I, quick aside here. It's, it's on topic, but before we move on, I mean, I, I'm not the first person to think this or say this, but I'll, I'll die on this hill. The more you use AI when, when you're using it the right way, right, the better leader and better specifically, the better communicator you'll become, right? Why? So much of interpersonal office drama, bad management, bad leadership is like what we talked about, right? It's poor communication. It's expecting people assumed something or had knowledge they didn't, right? It's not letting them know what you really wanted, what good work looks like, all that stuff. This is all context engineering, right, which is just a similar to prompt engineering, but context engineering is kind of the other more important piece these days with AI. What do I mean by that? Like I'm gonna give a prompt to a chat. Is it in just like a virgin chat or is it in a project? What context, what documents, skills, reference templates, et cetera, access to code bases does that project have, right? What am I telling it to do? How am I breaking that down? How am I, you know, big, high level goal? What do I want it to do? What does the output need to look like? How deep do I want it to go? Right? Like, how many questions I say, "Ask me like five or six questions" when I'm prompting, right, if I want that, right? Give, so giving the other person right in that space to say " What questions do you have?" Right? The, the, the best people at context engineering and leveraging AI in that way end up becoming more, better and better and better communicators because it's-- I mean, yes, you're talking to a machine, but at the same way, like those principles a hundred percent apply to good professional communication. So I'll die on that hill. There's a lot of people that are like brain rott using AI. It's " what's the weather today?" And you know, "how many calories does mayonnaise have?" And those people are not, you know, they're, they're not improving their leadership communication by using app, but the people actually doing it right a hundred percent are, [00:30:52] Lindsey Dinneen: Yes, I could not agree more. I think that is one of the coolest things that AI has taught me personally is-- to your point, to be a better communicator, to be clearer with the way that I communicate, to avoid assumptions that the other person, say, knows what I'm talking about or, or does have the context behind why I asked the question the way I did, or all those kinds of things. So I, I could not agree with you more. Yeah. And it's exciting to see how it continues to evolve. Okay. [00:31:22] Spencer Jones: Yeah. And why, real quick, why, like the AI models, especially with the reasoning models and stuff, Opus 4.6, all this stuff, telling them why they're doing something and why doing it, doing a certain task within that project flow is important is proving to be more effective than telling them how. And I think that's something where, you know, you tell someone what to do, they may do it, but if you tell them and make them believe why it's important, they do it that way, they're really gonna do it that way. [00:31:49] Lindsey Dinneen: Yeah. Love that so much. Okay. All right, so pivoting the conversation a little bit, just for fun. Imagine that you were to be offered a million dollars to teach a masterclass on anything you want, could be within your industry, but doesn't have to be. What would you choose to teach? [00:32:05] Spencer Jones: Does this, assume-- I have a question. Does this assume that I'm already I'm already capable and you know, have enough expertise to actually teach this class? Or is it like I choose this topic, I'm now an expert in that and I get to teach it? [00:32:19] Lindsey Dinneen: I like, I like I like both options, but I'm gonna go with option B because you have a million dollars to play with, right, so you could build up the expertise. Yeah. [00:32:29] Spencer Jones: You know, I would still say like building AI tools, AI agent systems, you know, skills and subagents and these flows and, and really tactically executing that for medtech. And that that goes from founder, you know, innovator to service provider, reg, quality ,reimbursement, like all the way up through sales and marketing and then like CDMO teams, you know, doing contract manufacturing, doing this. Like I, I just, I'm so passionate about it and I, I just see that there's so much untapped opportunity that that is the thing I think, and, and like we, we are doing that not a masterclass, but like we are working with groups to do some of that. But, I just, it's just so, so, so, so much opportunity to do it. And I think there's like weird structural reasons why it's not being adopted the same, you know, at the same clip it is in other industries. But you know, medtech's very rules-based game. You know, you've got your guidance docs, you've got your predicate devices, you've got your clinical trial protocols, you've got your stats analysis. You got your, you know, X, Y, Z hospitals get paid a certain way. Like lots of formulas, lots of reference material, lots of guidance docs. You know, it's very kind of rules and order based system in a lot of ways. And biology has its own kind of, prescriptive way that things happen, right? So I just feel like it's so primed for it. And anyways, I, I just, I wanna see it adopted more so we can see like what's happening with software now, where, you know, the cost to build and, you know, produce and get software to market has com has almost collapsed, but compressed to, you know, from like months, maybe years to, you know, days and weeks and, you know, you got a $200, 250 bucks worth of like software subscriptions, Claude this, that, the other, you can get it done in a week if you, you know, two weeks if you put your mind to [00:34:21] Lindsey Dinneen: Yeah. Yeah. No, that would be an incredible masterclass. I like it. All right. And then how do you wish to be remembered after you leave this world? [00:34:30] Spencer Jones: Oof. God, what a good question, Lindsey. You know, I hope to be remembered at all. [00:34:35] Lindsey Dinneen: Yeah. [00:34:36] Spencer Jones: You know, 'cause I, I'm definitely one of those people that's " nobody cares, nobody's thinking about you." You know, you may have, I, I mean, I think there's like some healthy main character syndrome that people can have that gives 'em confidence, but at the end of the day, no one cares. They're just, everyone's thinking about themselves. But if I am remembered, which I hope to be I wanna be viewed as like someone that was, I'd say, loved their family was a good dad, good husband. I would say brought people joy, was like fun to be around, but like from a interested in other people sense, you know, you know, genuinely cared about people. But I would say that on the professional side, like somebody that you know, would like consistently just delivered an absurd amount of value whether it was, you know, running a business or coaching and developing people at a company or working on behalf of clients or trying to make a positive change. I would say impactful and valuable, you know, with the work that I'm doing. That's, that's, that's how I wanna be remembered. I mean, we don't have big, I don't wanna be a unicorn billion dollar company. No, we have no desire to do that. We don't even have a, a desire to get acquired at any point. We're not raising money, you know, we've, we've deliberately chosen to bootstrap it. You know, we frankly just wanna employ really awesome smart people that we work with, you know, pay everybody well. And like I said, add a absurd amount of value you know, and joy to the people and the clients that we work with and like work at the company with, you know what I mean? [00:36:05] Lindsey Dinneen: Yeah. Yeah, that's a absolutely wonderful legacy to aspire to. I love it. All right. And then final question. What is one thing that makes you smile every time you see or think about it? [00:36:19] Spencer Jones: Oh, I gotta be, I've got a 1-year-old kid. Banks. Banks Austin Jones. So it's gotta be him, and my wife of course. One thing that makes me smile though, every time I see it, oh... you know, I am, I'll cry at a good TikTok, so I'm so I guess that's like a form of smiling, you know? But I'm a pretty big softie, honestly. You know, this is gonna sound weird, but it's kind of those moments where you know, people usually strangers and usually people that don't look like each other, just show humanity to each other. And that could be like holding a door open for somebody. It could be small things, you know what I mean? But I really love seeing those moments and capturing them like candidly, you know? Just you know, oh, I was in a restaurant, I saw this thing happen. You know? I really love that these days. [00:37:09] Lindsey Dinneen: Yeah. Yeah. We all need more of that these days too, so, yeah. Love it. Alright, well, Spencer, this has been a, a fantastic conversation. I really appreciate you and your time today. I love what you're building in the medtech industry and cultivating community and resources and providing value. So just thank you for everything you're doing to change lives for a better world. [00:37:34] Spencer Jones: Thank you. Can I ask you a question? I feel like you were so good, like with the questions and kind coming on the back of like my responses, but I have a question for you like what? You know, what about the medtech space, like most excites you? It can be a specific technology, it can be a specific, you know, company doing something. It can be anything, but what's most exciting to you, kind of looking at 2026 and, you know, kind of in the realm of medtech broadly. [00:38:00] Lindsey Dinneen: Yeah. Oh, I love that question. So I love this industry in general, but there, there's something really special about the energy of being around people who truly care about making a difference. Part of the reason I started The Leading Difference was because I, when I first joined, had sort of noticed this sort stigma from people from the outside who weren't very familiar with the innovation, what it takes to get from, you know, drawing to commercialization. Just didn't, just didn't know. And there was this stigma that people were here just for the money. And then I started meeting all of these incredible change makers who they had personal stories of what they were seeing, or a family member was impacted. And I just loved the fact that there were so many cool people doing such cool things and getting to play a small role in that was the coolest thing in the world. So, you know, I, I say I happily stumbled into medtech five years ago and found my people and my happy place, haven't looked back. I love it. I love being around people who are genuinely trying to do good things in the world. And I hear about new and you know, new ideas every day, and I get excited probably almost equally about most of them because it's just cool to see. So I don't know. Does that answer your question? [00:39:29] Spencer Jones: No, it, it does. I mean, it, it really the, it all comes back to the patient at the end of the day. And I definitely, I, I feel like when people think of like medical device stuff, like their minds immediately go to like Stryker sales reps or something, you know what I'm saying? And there's just so much more to it than that. And there's one of my favorite things about medtech is like the personalities, you know, like you got your wacky, you got your wacky inventors and you know, you got your straight laced regulatory people. But when you get to know 'em, they're, they're absolutely hilarious. You know, you got your attorneys, you got your like, and I, every industry, every industry has their personalities. But I think medtech, you know, you got your beef head sales reps that are like posting " What's up guys? I'm here in the locker room in my scrubs" and like "Motivation Monday." You're like, "Oh my God." But it's just like all these personalities and you go to these conferences and you just see 50 of the same person, but they're each different, they have their own dreams and conflicts and ideas and whatever, but they're still like so in the same box in some ways. I think that's one of the funnier, like funnier things about medtech that just makes it quirky, you know? [00:40:30] Lindsey Dinneen: I love it. And I also love the amount of respect that I see shared amongst people of very, very different backgrounds and areas of expertise. And that was one of the things that made me fall in love with the industry too. I was like, I, for instance, you know, I'm in, I'm in marketing and business development, so I play a very small role in, in sharing about these devices. But people, the engineers that I work with and the consultants that I work with, and everybody in the ecosystem is always just " Wow, well, I can't do what you're doing. And so I think what you're doing is fantastic." And so there's just, there's this mutual respect that I think is super cool about being here too. So yeah, I'm a fan. [00:41:08] Spencer Jones: Yeah, I agree. I agree. We could, we could keep going for, for days... [00:41:12] Lindsey Dinneen: I know. [00:41:13] Spencer Jones: ...On this. I really, I know, I know we have to wrap it, but but yeah. Well, Lindsey, thank you for having me. Seriously, this was a blast. And you know, I'll just maybe like quick sign off plug or something here. If anybody that's listening to this is like interested in, leveraging AI, leveraging AI in medtech or for you personally or whatever, follow me on LinkedIn and post a lot of content about it. You know, talk about it a lot on the podcast. But then if you're, if you're on the founder side, if you're an innovator, like join XO Medtech. If you're on the CDMO side, if you're, you know, on a sales and marketing team, contract manufacturer, CDMO, even like signed development groups, that kind of stuff like, you are like, "We know we need to be using AI to better leverage X, Y, Z, or do this thing. We have all these, we have HubSpot and this thing and that thing, and none of it works together well and we've got too many tools." Whatever. Just hit me up. Let's have a conversation. We're doing some absolutely incredible things leveraging AI, giving these sales and marketing teams like crazy leverage. So yeah, just drop a dm. I'd love to talk to you. [00:42:08] Lindsey Dinneen: Awesome. Sounds good. And we are so honored to be making a donation on your behalf as a thank you for your time today to the Polaris Project, which is a non governmental organization that works to combat and prevent sex and labor trafficking in North America. So thank you for choosing that organization to support, and we wish you continued success as you work to change lives for a better world. Looking forward to seeing the future of all the good things that you're doing. All right. Bye. [00:42:41] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

In just the past two months, Stryker, Intuitive Surgical, and Medtronic – three of the world's Top 100 Medical Device companies – have faced cyberattacks. Why are medtech companies becoming prime targets for hackers? What makes medical devices so vulnerable? And how is the FDA responding? In this episode of Let's Talk Medtech, Naomi Schwartz, VP of Regulatory Strategy at Medcrypt, breaks down: ✅ The anatomy of recent cyberattacks on leading medtech firms ✅ Why hackers are targeting the medical device industry ✅ What these breaches mean for patient safety and data security ✅ FDA's new cybersecurity requirements and what companies must do now

Boston Scientific Corp. v. Stryker Corporation

Can you break into Medical Device Sales without a background in sales?In this episode, Vidhi Patel shares the exact roadmap she used to transition from a Biology major and Clinical Researcher to an On-Site Specialist at Stryker, and finally landing her dream role in Breast & Skeletal Health Sales at Hologic.If you've been told you "don't have enough experience" or you've been stuck in a clinical role wanting to pivot to the business side, this interview is for you. Vidhi and I break down the tactical tools—from 30-60-90 Day Plans to the "About Me" PDF—that make a candidate undeniable to hiring managers.In this video, you will learn:Why the "On-Site Specialist" role is the best backdoor into sales.How to use LinkedIn to get noticed by top-tier recruiters.The secret to the "About Me" page that builds instant rapport with surgeons.Why you should let your company pay for your MBA (and why you don't need it to get hired).How to handle the grueling Stryker/Hologic interview process and the Gallup test.TIMESTAMPS:0:00 - Intro: Meet Vidhi Patel2:15 - Why Ohio State? (The OSU Connection)4:10 - From Clinical Research to Stryker On-Site6:45 - The Reality of the OR: Managing 3 Different Shifts9:30 - How LinkedIn and Networking Landed the Interview12:00 - Working with External Recruiters: What You Need to Know14:50 - The 30-60-90 Day Plan: Don't Just Copy/Paste!17:30 - The "About Me" PDF: The Secret Weapon for Rapport21:00 - Soft Skills: Reading the Room vs. Following a Script23:15 - Why Hologic? (A Personal Connection to Breast Cancer)25:30 - National Parks & Work-Life Balance in Med Sales29:00 - MBA vs. Experience: Which one matters more?31:30 - Advice for those stuck: "You just need one YES."Connect with Vidhi Patel:LinkedIn: https://www.linkedin.com/in/vidhipat/

Ringer, Margit www.deutschlandfunk.de, Deutschland heute

The Memphis Massacre was a truly horrific wave of destruction and violence, including sexual violence, against the Black community of Memphis just a year after the end of the U.S. Civil War. Research: “Memphis Daily Appeal Interviews Frances Thompson (1876),” SHEC: Resources for Teachers, accessed April 9, 2026, https://shec.ashp.cuny.edu/items/show/3717. “The Outrage Mill.” The North Missouri Register. 9/14/1876. “The Reports of the Committees of the House of Representatives Made during the First Session Thirty-ninth Congress, 1865-’66.” Washington: Government Printing Office. https://www.govinfo.gov/app/details/SERIALSET-01274_00_00-002-0101-0000/context Blank, Christopher. “Do The Words 'Race Riot' Belong On A Historic Marker In Memphis?” Code Switch. NPR. 5/2/2016. https://www.npr.org/sections/codeswitch/2016/05/02/476450908/in-memphis-a-divide-over-how-to-remember-a-massacre-150-years-later Britannica Editors. "Memphis massacre of 1866". Encyclopedia Britannica, 15 Feb. 2024, https://www.britannica.com/event/Memphis-Race-Riot. Accessed 8 April 2026. Carriere, Marius. “An Irresponsible Press: Memphis Newspapers and the 1866 Riot.” Tennessee Historical Quarterly , Spring 2001, Vol. 60, No. 1. https://www.jstor.org/stable/42628498 Davis, Justin A. “How a disabled Black trans woman left her mark on 19th-century Memphis.” The Emancipator. 6/13/2024. https://theemancipator.org/2024/06/13/topics/histories/how-a-disabled-black-trans-woman-left-her-mark-on-19th-century-memphis/ Donald, Bernice Bouie. “When the Rule of Law Breaks Down: Implications of the 1866 Memphis Massacre for the Passage of the Fourteenth Amendment.” Boston Law Review. Vol. 98. 2018. Equal Justice Institute. “On this day - Apr 30, 1866: White Police and Mobs Terrorize and Kill Black Residents in Memphis.” https://calendar.eji.org/racial-injustice/apr/30 Harper’s Weekly. “The Memphis Riots.” 5/26/1866. Johnson, Charles F. and T.W. Gilbreth. “The Freedmen’s Bureau Report on the Memphis Race Riots of 1866.” 5/22/1866. https://teachingamericanhistory.org/document/the-freedmens-bureau-report-on-the-memphis-race-riots-of-1866/ Kimberley, Lewis. “’If you kill him, you have got to kill me first’: examining individual and collective loyalties during the Memphis Massacre (1866).” American Nineteenth Century History. Vol. 25, 2024. https://www.tandfonline.com/doi/full/10.1080/14664658.2024.2316465 O’Donovan, Susan and Beverly Bond. “ ‘A History They Can Use’: The Memphis Massacre and Reconstruction’s Public History Terrain.” The Journal of the Civil War Era. 8/15/2016. https://www.journalofthecivilwarera.org/2016/08/history-can-use-memphis-massacre-reconstructions-public-history-terrain/ Stryker, Susan. “To Appear As We Please.” Aperture, Winter 2017, No. 229, Future Gender. Via JSTOR. https://www.jstor.org/stable/44898154 Walker, Barrington. “'This is the White Man's Day': The Irish, White Racial Identity, and the 1866 Memphis Riots.” Left History. Vol. 5, No. 2, 1997. https://doi.org/10.25071/1913-9632.5336 See omnystudio.com/listener for privacy information.

Cybersecurity expert Tony Grasso looks at a breach of Mastercom in Australia, a company that builds interoperable networks used by the emergency services. 

Knox Brew Stories is a weekly live radio show and podcast that offers an in-depth look into the beverages, businesses, artists, and inspiring humans who make Knoxville an amazing place to be!In this episode you'll find our regular weekly news about craft beer, as well as:Brew News (6:32)Live Music with Mike Jones (9:59)Interview with Kevin Summitt (19:10)Live Music with Cullen Kehoe (53:08)Next Week on Tap (1:03:17)Live Music with Sam Travis (1:05:37)Co-Host & Producer: Ace Preston Co-Host & Producer: Kevin SummittAudio Engineer: Clyde TimbsPodcast Producer: Asher CokerLinks for our featured Guests: https://www.instagram.com/mikuljoanz/https://linktr.ee/mikuljoanzhttps://www.instagram.com/cullenperformingsongwriter/https://www.facebook.com/CullenPerforming/https://www.instagram.com/sunnysammy865/Be sure to tune in live every Monday at 6pm EST at http://ChannelZradio.comAnd check out https://www.knoxbrewstories.com/ and https://www.instagram.com/suttreeshighgravity/

Nuestra  moderadora (host) Ivonne Arroyo Martínez, CEO de FranklinCovey Puerto Rico y República Dominicana, entrevista a la Sra. Yinet Ocasio Nieves,  Directora de Recursos Humanos y a Gabriel Rodríguez, Gerente de Recursos Humanos  de Stryker en Puerto Rico sobre la exitosa implementación de la Metodología  Lean Six Sigma Green Belt a proyectos de recursos humanos.Este episodio es auspiciado por AlChavo.com.SHRM-PR es una organización afiliada a SHRM.Moderadora-Ivonne Arroyo Martínez, CEO de FranklinCovey Puerto Rico y República DominicanaProducción Ejecutiva-Sociedad para la Gerencia de Recursos Humanos, Capítulo de PRAudiovisuales-Germarilis Ruiz,  Especialista Educativo SHRM-PR Edición-Víctor Maldonado, Director de Recursos Humanos SAL-PR 

Artificial intelligence is rapidly changing how people search for information, including how families learn about pregnancy and birth. As this technology grows, it raises important questions about accuracy, ethics, and the role of human expertise in healthcare information.   In this episode, Dr. Rebecca Dekker and Dr. Sara Ailshire share a behind-the-scenes look at how Evidence Based Birth® developed its own AI policies. They discuss concerns about misinformation, bias, privacy, and environmental impact, as well as the potential effects on critical thinking and human connection.   Learn why EBB has chosen to avoid the use of AI in our research, and what that means both for our team and for you.   (03:22) Why EBB began developing an AI policy  (10:39) Defining AI, generative AI, LLMs, and hallucinations  (17:03) Ethical concerns: Accuracy, bias, and risks to evidence-based information  (20:14) Environmental impact of AI and data centers  (21:47) Privacy concerns and data security risks  (26:21) Intellectual property, sustainability, and loss of research context  (27:03) Humanitarian concerns and the impact of AI on jobs and communities  (31:24) AI's potential effects on cognition and critical thinking  (37:30) Why EBB takes a cautious, evidence-based approach to AI  (38:20) Research team policy (42:06) Content team policy (45:01) Programs team policy and guidance for applicants  (47:32) Hiring practices and commitment to human review (52:29) Final takeaways: EBB's overall stance on AI    References Read EBB's Statement on Artificial Intelligence: ebbirth.com/artificial-intelligence-statement/ For a Student Who Used AI to Write a Paper, by Joseph Fasano: https://poets.org/poem/student-who-used-ai-write-paper Barrington, F. (2025). "Thirsty for power and water, AI-crunching data centers sprout across the West." & The West Magazine, Stanford University. April 8, 2025. https://andthewest.stanford.edu/2025/thirsty-for-power-and-water-ai-crunching-data-centers-sprout-across-the-west/ Gecker, J. (2025). "Big Tech is paying millions to train teachers on AI, in a push to bring chatbots into classrooms." Associated Press. October 20, 2025. https://apnews.com/article/artificial-intelligence-teacher-union-microsoft-f7554b6550fb90519dd8129acac8e291 Han, Y., Wu, Z., Li, P., et al. (2024). "The Unpaid Toll: Quantifying and Addressing the Public Health Impact of Data Centers." arXiv preprint arXiv: 2412.06288. https://arxiv.org/pdf/2412.06288 Hou, H., Leach, K., & Huang, Y. (2024). "ChatGPT Giving Relationship Advice - How Reliable Is It?" Proceedings of the Eighteenth International AAI Conference on Web and Social Media: 610–623. https://ojs.aaai.org/index.php/ICWSM/article/view/31338 Kosmyna, N., Hauptmann, E., Yuan, Y. T., et al. (2025). "Your Brain on ChatGPT: Accumulation of Cognitive Debt when Using an AI Assistant for Essay Writing Task." arXiv preprint arXiv:2506.08872. https://arxiv.org/abs/2506.08872 Marrinan, C. (2025). "Data Center Boom Risks Health of Already Vulnerable Communities." Tech Policy Press.com. June 12, 2025. https://www.techpolicy.press/data-center-boom-risks-health-of-already-vulnerable-communities/ NASA. (2024). "Defining Artificial Intelligence." Accessed November 17, 2025. https://www.nasa.gov/what-is-artificial-intelligence/ Notre Dame Learning. (2025). "AI Overview and Definitions." Accessed November 17, 2025. http://learning.nd.edu/resource-library/ai-overview-and-definitions/ Pataranutaporn, P., Karny, S., Archiwaranguprok, C., et al. (2025). "My Boyfriend is AI: A Computational Analysis of Human-AI Companionship in Reddit's AI Community." arXiv preprint arXiv:2509.11391.https://arxiv.org/pdf/2509.11391 Sonka, J. (2025). "The AI data center boom is coming for Kentucky. What will lawmakers do about it?" Kentucky Public Radio. December 9, 2025. https://www.lpm.org/news/2025-12-09/the-ai-data-center-boom-is-coming-for-kentucky-what-will-lawmakers-do-about-it Stryker, C. (n.d.) "What are LLMs?" IBM.com. Accessed November 17, 2025. https://www.ibm.com/think/topics/large-language-models Tabuchi, H. (2025). "Elon Musk's A.I. Company Faces Lawsuit Over Gas-Burning Turbines." New York Times. June 17, 2025. www.nytimes.com/2025/06/17/climate/naacp-musk-xai-supercomputer-lawsuit.html/ United Nations (UN). (2025). "AI has an environmental problem. Here's what the world can do about that." UN Environmental Programme. November 13, 2025. https://www.unep.org/news-and-stories/story/ai-has-environmental-problem-heres-what-world-can-do-about

Roderick Pugh enlisted in the U.S. Army less than three months before the 9/11 terrorist attacks. Eighteen months later, he was partr of 1st Brigade 2-7 infantry from Ft. Stewart, leading the way into Iraq. He would serve two tours in Iraq, In between, he completed airborne school and became the first African American sniper in U.S. Army history.In this edition of Veterans Chronicles, Pugh details combat during the invasion of Iraq, surviving  sandstorms and enemy mortar fire, and how the A-10 Warthogs were a huge help in the march to Baghdad. He also describes the intense fighting around the Baghdad airport and the engagement that earned him the nickname "Black Rambo"Pugh also tells us about airborne school and sniper training and explains the biggest reason why candidates fail to become snipers. He then takes us into his second deployment in Iraq with the 2-12 Cavalry out of Ft. Bliss. Pugh shares how his vehicle was hit by an IED and how he and others in his unit later dealt with enemies trying to plant IED's in the road.

Greg, Peter, Bobby, and Mike discuss a post-apocalyptic film that really tries out-lazy the rest of them. We got sand, some water, road warriors, cars, little people; it's everything you need for a great Grindbin episode. 

As healthcare organizations respond to the cyberattack on Stryker, the focus is shifting from what happened to how decisions are made in the moment. Gist Healthcare Podcast host J. Carlisle Larsen speaks with Phil Englert of Health-ISAC about navigating uncertainty during an incident, how these events shape perceptions of medical device risk, and what it takes for organizations to coordinate under pressure. You can listen to the first half of the conversation here. Hosted on Acast. See acast.com/privacy for more information.

Imagine logging in one morning and - poof - everything's gone. Not locked, not held hostage… just gone. That's the kind of cyberattack making waves right now, and it's not your typical "pay me in Bitcoin" situation. In this episode, we unpack the Stryker cyberattack,  a real-world incident that shows how attackers are shifting from making money to making a mess, and why that should have everyone in healthcare (and beyond) just a little more on edge.  More info at HelpMeWithHIPAA.com/553

On this week's show, Patrick Gray, Adam Boileau and James WIlson discuss the week's cybersecurity news. They talk through: TeamPCP's supply chain attack on Github, and they threw in an anti-Iran wiper, because why not?! Anthropic hooks up its models to just… use your whole computer After Stryker's Very Bad Day, CISA says maybe add some more controls around your Intune? Another iOS exploit kit shows up in the cyber bargain-bin The FTC decides to ban… all new home routers?! U wot m8?! Supermicro founder was personally sanction-busting Nvidia GPUs into China?! This week's episode is sponsored by enterprise browser maker, Island. Chief Customer Officer Bradon Rogers joins Pat to explain how its customers are using Island to control the use of personal AI services in regulated industries. This episode is also available on Youtube. Show notes ‘CanisterWorm' Springs Wiper Attack Targeting Iran TeamPCP deploys CanisterWorm on NPM following Trivy compromise Andrej Karpathy on X: "Software horror: litellm PyPI supply chain" attack Checkmarx KICS GitHub Action Compromised: Malware Injected in All Git Tags Felix Rieseberg on X: "Today, we're releasing a feature that allows Claude to control your computer" A Top Google Search Result for Claude Plugins Was Planted by Hackers Lockheed Martin targeted in alleged breach by pro-Iran hacktivist CISA urges companies to secure Microsoft Intune systems after hackers mass-wipe Stryker devices FBI seems to seize website tied to Iranian cyberattack on Stryker Stryker confirms cyberattack is contained and restoration underway Hundreds of Millions of iPhones Can Be Hacked With a New Tool Found in the Wild Someone has publicly leaked an exploit kit that can hack millions of iPhones Russia-linked hackers use advanced iPhone exploit to target Ukrainians Apple rolls out first 'background security' update for iPhones, iPads, and Macs to fix Safari bug Post by @wartranslated.bsky.social — Bluesky Signal's Creator Is Helping Encrypt Meta AI Hacker says they compromised millions of confidential police tips held by US company Millions of 'anonymous' crime tips exposed in massive Crime Stoppers hack Feds Disrupt IoT Botnets Behind Huge DDoS Attacks FCC bans import of consumer-grade routers amid national security concerns White House pours cold water on cyber ‘letters of marque' speculation Google launches threat disruption unit, stops short of calling it ‘offensive' Supermicro's cofounder was just arrested for allegedly smuggling $2.5 billion in GPUs to China Cyberattack on vehicle breathalyzer company leaves drivers stranded across the US Man pleads guilty to $8 million AI-generated music scheme Two Israelis AI generated "intelligence" and sold it to Iran

A cyberattack on Stryker disrupted operations across one of the largest medical device companies in the world, affecting ordering, manufacturing, and shipping and prompting hospitals to assess potential impacts. Unlike most healthcare cyber incidents, this was not a typical ransomware attack. In this episode, Gist Healthcare Podcast host J. Carlisle Larsen speaks with Phil Englert of Health-ISAC about what made the incident unusual and what it reveals about how healthcare organizations may need to rethink their response when an attack is focused on disruption rather than payment. Hosted on Acast. See acast.com/privacy for more information.

Feds take down major IoT botnets. The FBI seizes hacktivist infrastructure. A data breach hits Kaplan, while a hacker claims access to millions of law enforcement tips. Fake Zoom calls deliver malware. A crypto “security” tool turns out to be spyware. A critical AI framework flaw gets exploited in hours. An insider extortion case ends in conviction. And a streaming scam pulls in over $10 million. A look back at ten years of Cyberwire podcasts. Intern Kevin gets ready for RSAC. A cyberattack leaves breathalyzers offline.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. Celebrating CyberWire Daily Maria Varmazis leads a conversation with Peter Kilpe and Dave Bittner reflecting on the origins of the CyberWire Daily podcast as part of the 10th anniversary series, sharing behind-the-scenes insights and how it all got started. CyberWire Guest Today we are joined by Intern Kevin—also known as Kevin Magee—as he gets ready for RSA Conference 2026 next week. Selected Reading Feds disrupt IoT botnets behind record-breaking DDoS attacks (The Register) FBI seizes Handala data leak site after Stryker cyberattack (Bleeping Computer) Kaplan North America Reports Data Breach Impacting Nearly 195,000 Individuals (Beyond Machines) Hacker says they compromised millions of confidential police tips held by US company (Reuters) Fake interactive Zoom call leads to malicious ScreenConnect download | news (SC Media) Crypto Scam "ShieldGuard" Dismantled After Malware Discovery (Infosecurity Magazine) Hackers Exploit Critical Langflow Bug in Just 20 Hours (Infosecurity Magazine) Ex-data analyst stole company data in $2.5M extortion scheme (Bleeping Computer) Musician admits to $10M streaming royalty fraud using AI bots (Bleeping Computer) Cyberattack leaves Maine drivers with breathalyzer test systems unable to start vehicles (WGME) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

The EU imposes sanctions after cyberattacks. DHS boosts surveillance spending. AI firms recruit weapons-risk experts. Stryker disruption, no patient impact. LeakNet leans on ClickFix. Sears chatbot data spills. A Chinese security firm leaks a private key. Tech giants team up on scams. Teens sue xAI over alleged AI-generated abuse. On today's Threat Vector segment, David Moulton and guest Erica L. Shoemate, founder of The EN Strategy Group, explore how AI is fundamentally reshaping the security landscape. Cyber crooks cause a complimentary curbside convenience.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. Threat Vector What if the choices we make about AI security today determine who holds power tomorrow? On this Threat Vector segment, David Moulton and guest Erica L. Shoemate, founder of The EN Strategy Group, explore how AI is fundamentally reshaping the security landscape, from compressed decision-making timelines and asymmetric threat capabilities to the erosion of trust that creates strategic vulnerabilities. You can listen to David and Erica's full conversation here and catch new episodes of Threat Vector from Palo Alto Networks each Thursday on your favorite podcast app. Selected Reading EU Sanctions Iranian and Chinese Firms for Cyberattacks Against European Networks (TechNadu) DHS-built surveillance apparatus to surge in year ahead, documents show (FedScoop) AI firm Anthropic seeks weapons expert to stop users from 'misuse' (BBC) Stryker attack wiped tens of thousands of devices, no malware needed (Bleeping Computer) LeakNet ransomware uses ClickFix and Deno runtime for stealthy attacks (Bleeping Computer) Sears Exposed AI Chatbot Phone Calls and Text Chats to Anyone on the Web (WIRED) China's biggest cybersecurity firm accidentally leaked an SSL key in a public installer (Neowin) Google has signed the Industry Accord Against Online Scams and Fraud. (Google) Teenage girls sue Musk's xAI, accusing Grok tool of creating child sexual abuse material (The Guardian) Free parking in Russia after Distributed Denial-of-Service attack knocks city's parking system offline (Bitdefender) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Drone strikes hit a key chip supply chain. China-linked hackers target Southeast Asian militaries. Attackers race ahead with AI. ShinyHunters claim a massive Telus breach. Microsoft issues a hotpatch. Malware turns up on Steam. Fileless attacks grow. Airline miles become cybercrime currency. Monday business breakdown. Tim Starks from CyberScoop unpacks the Stryker attack and the nebulous nature of Iranian cyber activity. AI playmates puzzle preschoolers.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Our guest is Tim Starks from CyberScoop discussing how the Stryker attack highlights the nebulous nature of Iranian cyber activity amid joint U.S.-Israel conflict. You can read more in Tim's article here.  Selected Reading Drone strikes halt a third of the world's helium supply, threatening chip production (TechSpot) China-Linked Hackers Hit Asian Militaries in Patient Espionage Operation (SecurityWeek) Attackers are exploiting AI faster than defenders can keep up, new report warns (CyberScoop) Telus Digital confirms breach after hacker claims 1 petabyte data theft (Bleeping Computer) Microsoft releases Windows 11 OOB hotpatch to fix RRAS RCE flaw (Bleeping Computer) The FBI is investigating malware hidden inside games hosted on Steam (TechCrunch) New XWorm 7.1 and Remcos RAT Attacks Abuse Windows Tools to Evade Detection (Hackread) Airline miles become underground currency in loyalty fraud schemes | brief (SC Media) Kevin Mandia-founded Armadin launches with $190 million. (N2K Pro Business Briefing) AI toys for young children need tighter rules, researchers warn (BBC News) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show.   Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, pro-Iranian hackers claimed responsibility for a devastating cyberattack against U.S. medical device company Stryker. They have also targeted data centers and industrial facilities in both the United States and Israel. As the war with Iran continues, experts are expecting an increase in such cyber-attacks in an effort to degrade the war effort, strain cyber security efforts and cause as much damage to American companies, and the economy as possible. FOX's Tonya J. Powers speaks with Michael Crean, Senior Vice President of Managed Services at SonicWall, a comprehensive, AI-driven cybersecurity solutions company that specializes in next-generation firewalls and cloud security, who says the goal is to wear down the war effort and hit Americans at home. Click Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To Follow 'The FOX News Rundown: Evening Edition' Learn more about your ad choices. Visit podcastchoices.com/adchoices

March 12, 2026; Nicolle Wallace delivers the latest on an attack at Temple Israel, a synagogue in West Bloomfield, and a shooting at Old Dominion University in Norfolk. We discuss what we know so far about the perpetrators and updates with Michael Feinberg, Mark Mazzetti and Ken Dilanian. More on the context as Pro-Iran hackers targeted American company Stryker with Alex Wagner and Steve Liesman. For more, follow us on Instagram @deadlinewh For more from Nicolle, follow and download her podcast, “The Best People with Nicolle Wallace,” wherever you get your podcasts.To listen to this show and other MS podcasts without ads, sign up for MS NOW Premium on Apple Podcasts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

P.M. Edition for Mar. 12. The economic risks of the war in Iran are getting real on Wall Street. Brent crude jumped above $100 a barrel and U.S. stocks sold off. Plus, the tie-up in the Strait of Hormuz is rippling across the global economy, and that includes sending the price of fertilizer skyrocketing. We hear from Journal agriculture reporter Patrick Thomas about what this means for U.S. farmers going into the spring planting season. And employees of medical-technology company Stryker woke up yesterday to find that their devices had been disabled due to a cyberattack. James Rundle, who covers cybersecurity for WSJ Pro, discusses how the war in the Middle East is playing out in the world of hackers. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's Headlines: Twelve days in, the Iran war has cost $11 billion and nearly 2,000 lives. The most damning number: 175 people — mostly children — killed when a U.S. Tomahawk missile hit an Iranian elementary school because the Defense Intelligence Agency used outdated targeting data. Trump is still blaming Iran. He spent yesterday in Kentucky rallying against Thomas Massie and bragging the war was over "in the first hour." US intelligence disagrees: Iran's government is intact and now led by a younger, more radical Supreme Leader. Trump and Netanyahu are also diverging — Trump wants a victory banner, Israel wants regime change. Hezbollah is firing rockets into Israel; Israeli strikes have displaced over 700,000 people in Lebanon. Iran has escalated in the Strait of Hormuz, hitting three commercial ships and threatening every regional port. The US and IEA announced one of the largest emergency oil reserve releases in history after the Trump administration reversed course in two hours. February inflation already showed fuel oil up 11.1% before any of this started.  The FBI is warning California law enforcement about potential Iranian drone strikes launched from ships off the coast, and thousands of Stryker employees — the company makes robotic surgery systems — arrived to find their devices locked with an Iran-linked hacking group's logo on their screens. A government watchdog found Hegseth's Pentagon burned $93 billion in September 2025 alone. The last five days of that month's spending exceeded Canada and Mexico's combined military budgets. Trump is threatening to veto all legislation until the SAVE Act — which would significantly restrict voting access — clears the Senate, while DHS investigates Arizona's 2020 election results and targets swing states ahead of the midterms. Epstein's accountant testified before House Oversight in a closed session; one detail leaked: a Trump accuser reportedly received a settlement from the Epstein estate. And a 12-foot gold statue appeared on the National Mall depicting Trump and Epstein in the Titanic bow pose — Epstein as Rose — with plaques noting their friendship was "built on luxurious travel, raucous parties, and secret nude sketches." Resources/Articles mentioned in this episode: NYT: ⁠First Week of Iran War Cost More Than $11 Billion, Pentagon Tells Congress⁠ NYT: ⁠U.S. at Fault in Strike on School in Iran, Preliminary Inquiry Says⁠ ABC News: ⁠Iran live updates: US senators told Iran war cost $11.3B in first 6 days⁠  NBC News: ⁠Live updates: Trump goes after Rep. Thomas Massie in Kentucky congressman's district⁠ ABC News: ⁠Iran live updates: US senators told Iran war cost $11.3B in first 6 days⁠ Reuters: ⁠Exclusive: US intelligence says Iran government is not at risk of collapse, say sources⁠ WSJ: ⁠Trump Says the Iran War Is Nearly Won but Israel Has Other Ideas⁠ ABC News: ⁠Iran live updates: US senators told Iran war cost $11.3B in first 6 days⁠ Axios: ⁠IEA announces historic oil reserve release amid Iran war⁠ WSJ: ⁠President Trump's Head-Spinning Pivot on an Emergency Oil Release⁠ Politico: ⁠Energy, food prices surged in February — before Iran fighting started⁠ ABC News: ⁠FBI warns Iran aspired to attack California with drones in retaliation for war: Alert⁠ WSJ: ⁠Iran Expands War With Major Cyberattack Against U.S. Company⁠ The New Republic: ⁠Pete Hegseth Blew Billions on Fruit Basket Stands, Chairs, and Crab⁠ NYT: ⁠Thune Is in a Vise as Trump and Far Right Demand Fight on Voter Bill⁠ ABC News: ⁠Trump administration opens investigation into Arizona's 2020 election results⁠ NYT: ⁠Trump Wants to ‘Take Over' Elections. These States Are Prime Targets⁠ Mediate: ⁠BOMBSHELL: Trump Accuser Got Payoff from Jeffrey Epstein Estate, Says Dem Lawmaker⁠ The Guardian: ⁠New satirical statue depicts Trump and Epstein as doomed lovers from Titanic⁠ Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

Iran threatens tech firms as hackers strike Stryker. The EU advances efforts toward digital sovereignty. A foreign hacker stumbles upon the FBI's Epstein files. DOGE used ChatGPT to cull humanities grants. Meta claims increased efforts against scams. A Wisconsin ambulance provider discloses a data breach. CISA shortens the patch deadline for a critical SolarWinds vulnerability. We preview this year's RSAC 2026 Innovation Sandbox with Cecilia Marinier and Paul Kocher. Dangerous digital diets miss the mark.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest On our Industry Voices segment, we share a RSAC 2026 Conference innovation preview with Cecilia Marinier and Innovation Sandbox judge Paul Kocher talking about this year's Top 10 Finalists. Selected Reading Iran-linked hackers claim responsibility for attack on US medical device maker Stryker (Reuters) 'Legitimate targets': Iran issues warning to US tech firms including Google, Amazon, Microsoft, Nvidia (The Times of India) Iranian trolls are flooding social media with pro-Tehran, anti-war propaganda (MS Now) Commission announces €75 million EURO-3C Project to build a federated Telco-Edge-Cloud infrastructure for digital sovereignty (European Commission) Hacker broke into FBI and compromised Epstein files, report says (TechCrunch) When DOGE Unleashed ChatGPT on the Humanities (The New York Times) Meta says it culled millions of scam ads amid accusations that it profits from them (The Record) Bell Ambulance Ransomware Attack Impacts Over 237,000 Individuals (Beyond Machines) CISA Mandates Emergency Patching for SolarWinds Web Help Desk Vulnerabilities (Beyond Machines) AI Chatbots Are Giving Teens Absolutely Terrible Diet Advice, Study Warns (Gizmodo) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

As U.S. and Israeli forces continue to dimmish Iran's military capabilities, Tehran is moving towards more asymmetrical warfare with cyberattacks and the cutting off of the important trade route of the Straight of Hormuz. Iran's proxy groups using low end drones and speedboats to attack on U.S. and other Mideast nation's owned oil and energy infrastructures aim to damage the worked economy. Meanwhile, a U.S. medical device company, Stryker, confirmed they experienced a cyberattack focused on their Microsoft platform that shares patient information and real time data. More cyberattacks, like the one on Stryker, are feared to be coming as politically motivated hackers act like digital sleeper cells. FOX's Jonathan Savage speaks with Bill Udell, former CIA Operations Officer and Analyst, and the Chief Executive Officer, The Americas at Control Risks, bringing expertise in risk management and international operations, who says Iran's low sophisticated weaponry and attack capabilities could still cause major problems. Click Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To Follow 'The FOX News Rundown: Evening Edition' Learn more about your ad choices. Visit podcastchoices.com/adchoices

When Dr. Linda Goudey was found strangled to death in October 1993, the main suspect was her boyfriend, Timothy Stryker, who was also a doctor. Nothing police found at the scene pointed directly to Stryker, and it took years for him to plead guilty, but it wasn't to murder charges. “48 Hours" Correspondent Richard Schlesinger reports. This classic "48 Hours" episode last aired on 6/13/2009. Watch all-new episodes of “48 Hours” on Saturdays, and stream on demand on Paramount+. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices